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A B  TRACT 
Oiabete Mel l i tus (OM) is  currently the fastest growing di sease i n  the world The 
prevalence ofDM has increased worldwide and is expected to double withm 20 years 
The AE'1 k d ran e 1 5th worldwide, with 1 8  98% of the UAE population l iving with 
diabetes Middle Ea t orth Africa (MENA) region countries - Bahrain, Egypt, 
Kuwait, Oman, audi Arabia, and the United Arab Emirates (UAE) - are among the 
world' 1 0  highest for prevalence of diabetes and impaired glucose tolerance. This 
repre ents a huge co t to society in  terms of morbidity and mortali ty, and 
economical ly through lost product ivity and cost burden on the healthcare system In  
2009 mortal ity l in ked to  DM constituted 75% percent of  the deaths among UAE 
nat iona ls  and 3 1 % among non-nat ionals .  The Goto-Kakizaki (GK) rat i s  one of the 
best characterized genet ic  animal models of T2DM. A variety of contract i le 
dysfunctions, associated with alterations i n  intracel lu lar Ca2
+
, have been demonstrated 
in GK rat heart The consumption of sugar-sweetened beverages has been l i nked to 
rising rates of obesity which in turn is a ri sk factor for development of T2DM. 
In  these experiments, GK and Control rats received either normal dri nk ing water or 
drink ing water contain ing sucrose ( 1 00-400mM )  for either 6 or 8 months After 6 
months of d ietary intervent ion the ampl itude of ventricular myocytes shortening and 
Ca2 transient were not significantly altered in either GK or Control rats. 
After 8 months, ampl itude of shortening was decreased in ControVSucrose and i n  
GKiSucrose rats compared to Control and GK rats respect ively. interest ingly, the 
ampl itude of the Ca2
� 
transient was i ncreased in myocytes from ControVSucrose and 
decreased in GKJSucrose compared to Control and GK rats 
Expression of genes encoding a range of ventricular muscle proteins were also 
investigated i n  ventricular t issue after 8 months of dietary intervention Genes 
VI  
encoding cardiac muscle prot eins (Myh7, Myb pc3 , Myl ,  My13, Mylpt) ,  int ercellular 
prot eins (Gja4), cel l memb rane t ransport (At p  1b 1 ), calcium channel s (Cacnal c, 
acna 1 g, Cacnb 1 ), pot a  sium channel s (Kcnj 1 1 ) were upregulat ed in GK compared 
t o  Cont rol rat s Genes encoding pot assium channels (Kcnbl ) were decreased in GK 
compared t o  Cont rol rat s Genes encoding cardiac muscle prot eins  (Myh6, Myb pc3, 
Tnn2), int ercel lu lar prot eins (Gjal ,  Gja4), int racel lular Ca2 t ransport (At p2al ,  Ryr 2), 
cell memb rane t ransport ( At p  l a2,  At p Ibl ), pot assium channel (Kcnj2, Kcnj8)  
prot eins were upregul at ed in Cont rol/Sucrose compared t o  Cont rol rat s Genes 
encoding cardiac muscle prot eins ( Myh7) were downregulat ed in Cont rol/Sucrose 
compared t o  Cont rol rat s Genes encoding cardiac muscle prot eins ( Myh7), pot assium 
channel ( Kcnj 1 1 ) prot eins were downregu lat ed in  GKJSucrose compared t o  Cont rol 
rat s 
I n  conclusion, sucrose-enriched diet s  alt ered diet ary hab it s in  GK and Cont rol rat s  and 
exacerb at ed diab et ic st at us in GK rat s. Subt le changes in expression of genes 
encod ing a variet y  of vent ricular muscle prot eins are associat ed wit h  changes i n  
vent ricular myocyte short en ing and int racel lu lar Ca2 t ransport i n  vent ricular 
myocytes from GK T2DM and Cont rol rat s fed a sucrose-enriched diet .  
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CHAPTER! 
INTRODUCTION 
1 
1 .  I TRO DUCTION 
1 . 1  D J A B ETE  M ELLITUS 
1.2  DEF I N I T I O  O F  D I A B ETES MELLITUS 
Diabetes Mel l i tus (DM) is a heterogeneous group of metabol ic di sorders characterized 
by hyperglycemia ,  polyuria and polydipsia Such symptom are either due to 
in ufficient i nsul i n  production by the pancreas or to insulin resistance, where target 
cel l s  are no longer responding adequately to secreted insul in 
1 . 1 . 2 EPI D EMIOLOGY OF DIA BET ES MELLITUS 
DM is  currently the fastest growing disease in  the world The est imated global 
prevalence of DM is around 8 .3% of adults, 382 mi l l ion people have diabetes, and the 
number of people with the di sease is set to rise beyond 592 mi l l ion by 203 5 (Diabetes 
A tlas International DIabetes Federation 201 3) .  Whi l st the prevalence of diabetes 
ha i ncreased i n  Europe and orth America, it is clear that much of the i ncrease is in  
the developing countries, and th is  number i s  expected to i ncrease by two thirds i n  less 
than 20 years as a result of an i ncrease in  obesity and longevity (Chaturvedi, 2002; 
Gakidou 2011 , Rathmann & Giani , 2004). 
1.1.3 CA LSSIFICA TION OF DIABETES MELLITUS 
Diabetes Mel l itus can be class ified i nto several types, but there are two major types, 
type 1 diabetes mel l itus (T1 DM )  and type 2 diabetes mel l itus (T2DM) (Report of the 
expert committee on t he d iagnosis and classificat ion of diabetes, 2003 ).  
T I DM is somet imes cal led immune-mediated or juveni le-onset diabetes. I t  accounts 
for 5-1 0% of a l l  cases of DM. T I DM is understood to result from immune-mediated 
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destruction of p-cel l s  which produces insul in  in  the pancreat ic i sl ets of Langerhan 
(Diagnosi s and classi fication of diabetes mel l itus, 20 1 1 )  People with TI DM produce 
very l itt le or no insu l in . The d i sease can affect people of any age, but usually occurs 
in chi ldren or young adu lts 
T2DM is  omet imes cal Jed adult-onset diabetes, and accounts for 90-95 % of al l cases 
of OM ( Oiagno is and cia ification of diabetes mell itus, 20 1 1 )  I t  i s  characterized by 
insu l in  resistance and relative insul in  deficiency, either of which may be present at the 
t ime that OM i s  manife ted c l in ical ly The diagnosi s ofT2DM usual ly occurs after the 
age of 40 but can occur earl ier, especial ly in populat ions with high prevalence ofDM 
It  i s  often, but not always, associated with obesity, which itself can cause insul i n  
resi stance and lead to elevated blood glucose levels (Diagnosis and classificat ion of 
diabetes mel l itus, 20 1 1; Types ojdlGbetes, 20 1 3 ) .  
1 . 1 .4 COMPLICATIONS O F  D I ABETES M ELLITUS 
Diabetes is a chronic medical condit ion, meaning that although it can be control led, it 
l asts a l i fe rime, and without careful monitori ng and fol low up it can damage various 
organs in the body DM compl ications can be categorized as acute and chromc. 
1 . 1 .4. 1  Acute Com plicat ions of Diabetes Mell itus 
Diabet ic ketoacidosis (DKA) and non-ketotic hyper-osmolar state (NKHS) are acute 
l i fe threatening comp l i cations of OM (El lemann et al., 1 984; Tokuda et ai. ,  20 1 0). 
DKA is seen primari ly in i ndividuals with T 1 0M whi le NKHS i s  prevalent i n  
individuals with T2D M  (Chiasson et al., 2003 ). DKA is  a state of  absolute or relative 
insu l in  deficiency aggravated by ensuing hyperglycemia, dehydration and acidosi s 
(Chiasson et at. , 2003 ). DKA pat ients usual ly present with abnormal vital signs due to 
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hemodynamic and metabohc imbalance (Burge el aI , 200 1 ,  Guh et aI., 1 997). 
Dehydrat ion, hypovolemia, electrolyte imbalance or infect ion may lead to cardiac 
arrhythmias including tachycardia (Burge el al
., 200 1 ) A typIcal sign in DKA 
patient i Kussmaul's respiration which i s  characterized by deep respi ratory effort 
and tachypnea which compen ates metabol ic acidosi s (Minagar & Weiner, 200 1 )  On 
the other hand, KH which causes a simi lar hemodynamic abnormal ity i s  
comparat i e l y  rare, but has a worse prognosis (Tokuda el aI., 20 1 0). Both DKA and 
NKHS need urgent diagnosi and management 
1 . 1 . 4. 2  Chronic Com plica t ions of Diabetes Mell i tus 
Although long-term compl ications of diabetes develop gradual ly, they can eventual ly 
be di abl ing or even l i fe-threatening. The chronic compl ications are main ly the resu lt 
of longstanding damage to blood vessels affect ing many organ systems and are 
re ponsible for the majority of morbidity and mortal ity. These compl ications of DM 
can be divided into vascular and nonvascular compl ications. onvascular 
compl icat ions i nclude problems such as gastroparesis, sexual dysfunction, and skin  
changes (Tripathi & Srivastava, 2006). 
The vascular compl icat ions are further subdivided into microvascular (retinopathy, 
neuropathy, and nephropathy) and macrovascul ar compl ications (coronary artery 
disease, peripheral vascular disease, and cerebrovascular disease (Cade, 2008) 
Diabet ic reti nopathy is  a microvascular compl jcation that can affect the peripheral 
reti na, the macula, or both and i s  the leading cause of bl indness in adults with DM 
(A l i  & EI-Remessy, 2009). Diabet ic retinopathy is characterized by microvascular 
basement membrane th ickening which impairs the diffusion of oxygen and nutrients 
to the ret ina leading to neo-vascu lar prol i feration resu lt ing in  vary ing degrees of 
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mlcroaneurysms and hemorrhages (Harding, 2003 ). The spectrum of the disea e 
ranges from non-prol iferat ive to proliferat ive depending on the extent of retinal 
change and the degree of microvascular growth (Cade, 2008, Harding, 2003) 
Diabetic neuropathie are characterized by progressive loss of nerve fiber function. 
europathie are the mo t common compl icat ion of DM, affecti ng up to 50% of 
pat ient with T 1 DM and T2DM (Cade, 2008, Dyck ef aI., 1 993 ).  
Diabet ic patients may al 0 have autonomic neuropathy, especial ly cardiovascular 
autonomic dysfunction, such as rest i ng tachycardia and exercise intolerance (Vinik et 
at., 2003 ) 
Diabet ic nephropathy i s  a progressIve k idney disease caused by angiopathy of 
capi l larie m t he k idney glomeruli ( Abe, 20 1 1 ) . I t  is presented typical ly by 
microalbuminuria, which progresses to overt albuminuria and eventual ly to renal 
fai lure ( Drummond & Mauer, 2002) .  This is a maj or cause of end-stage renal di sease 
1 . 1 .4.3 Card iovascular M orbidity and M ortali ty in Diabetes Mellitus 
DM is considered a major risk factor for cardiovascular di sease (Rathmann & Giani, 
2004) Several recent studies have shown the effects of DM on the heart. 
DM is associated with an increased risk of cardiovascular death ( �70%) and a higher 
i ncidence (4 t imes greater) of cardiovascular di seases (Cade, 2008) i ncluding 
coronary artery di seases, congestive heart fai lure and atrial fibril lation (Huxley et aI., 
20 1 1 ,  Poulsen el aI., 20 ] 0). 
Many studies have reported an i ncreased i ncidence of cardiac conduction 
abnormal it ies, such as right bundle branch block., bi-fascicular b lock and high degree 
AV-block, in pat ients with DM. Causes of cardiac conduct ion abnormalit ies in DM 
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pat ients may i nclude autonomic neuropathy and DM-associated cardiova cular 
d i  ea e or channelopathie (Movahed, 2007). 
OM i strongly correlated to heart fai lure (HF), OM may play a role i n  the 
pathogene i , prognosis and response to treatment of HF (Solang, 1 999) and a 
igni ficant proportion of pat ients with HF are diabetics There are at least 3 
mechani m by which H F  can develop in  d iabet ic pat ients; due to associated 
comorbidit ies, by favouring the development of coronary atherosclerosis, or through a 
specific diabet ic cardiomyopathy 
As ociated comorbidit ies includes dysl i pidaemia, hypertension, hypercoagulabi l ity, 
obe it and inflammat ion which are all part of the insu l in  resi stance syndrome 
Diabet ic pat ients show a higher risk of atherosclerosi s, which may later cause HF . 
Thi i ncreased risk of atherosclerosis i n  diabetics can develop as a resu lt of 
endothel ial dysfunct ion (Nitenberg et aI., 1 998), or altered haemostatic factors (higher 
level of fibri nogen)  (Ceriel lo, 1 993),  or plasminogen act ivator-inhibitor- 1 (Nordt et 
aI., 1 995 ,  Sobel et aI., 1 998), or altered platelet function. 
The third suggested mechanism for HF in  diabetic patients i s  a consequence of 
diabet ic m icroangiopathy, endothel ial dysfunct ion, metabol ic  abnormal it ies, and 
fibrosis which leads to the development of what is known as diabet ic cardiomyopathy 
( Nahser et aI. ,  1 995,  N itenberg et al., 1 998, 1 993 ; Rubler el aI., 1 972). 
1 . 1 .5 A N I M A L  M O D E LS OF D IABETES M ELLITUS 
Experimental animal models  have been used for many years for the study of DM. 
They give researchers the opportunity to control genet ic and environmental factors 
that may influence the development of the disease and its compl ications, and thus gain 
i nformat ion about its management i n  humans (Chatzigeorgiou el aI. , 2009). 
6 
1 . 1 .5. 1 H i  tory of A n i mal Model of Diabetes Mel l i tus 
The earl t e  t animal model of OM was discovered accidentally A pancreatomized dog 
wa u ed to evaluate intest inal fat absorption i n  the 1 880s by Minkowski The ani mal 
developed polyuria and polydipsia and was identi fied to have DM Pancreatomized 
animal model including rabbits and dogs have been used in diabetes re earch Over 
the year , a number of antmal models have been establ ished for studying OM or 
te  tmg anti-diabetic agent Experimental animal models are mostly rodents, as they 
are smal l ,  easy to handle, have a short l ife span and are relatively cheap (Rees & 
Alcolado, 2005) .  
1 . 1 .5.2 Experi m ental Models of Type J Diabetes Mell i tus 
TIDM i caused by T cel l-mediated destruction of pancreat ic �-cel l s) with relative or 
complete insu l in  defici ency ( Daneman, 2009) Whi l e  the damage may occur si l ently 
over years, at c l in ical presentation there are few surviving cel l s  and the di sease 
progresses to absolute i nsul i nopaenia (Rees & Alcolado, 2005). 
1 . 1 . 5.2 . 1 Surgically I n d uced Type 1 Diabetic Models 
This t echnique comprises complete or partial pancreatectomy in animals used for the 
induct ion of T l DM or T2DM, respectively (Sr in ivasan & Ramarao, 2007) 
1 . 1.5.2.2 Chemically I n d uced Type 1 Diabetic M odels 
Streptozotocin (STZ) induced diabetes mel l itus ' STZ I S  a nitrosurea derivat ive, 
i solated from fermentations of Streptomyces achromogenes that i s  classical ly an anti­
tumour antibiot ic and chemical ly is related to other njtrosureas used in  cancer 
chemotherapy ( Bono, ] 976). STZ sel ect ively accumulates in  the pancreatic �-cel ls  via 
the GLUT2 glucose transporter and destroys them through reactive oxygen species 
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and free radical mechani m (Chatzigeorgiou et al., 2009) p-cel l s  have relativel high 
level of GL T2 ( chnedl ef al., 1 994), which explains the sel ect ive toxicity of TZ 
for p-cel l  (Sakata et aI., 20 1 2) This wi l l  eventual ly result in  i nsul in defici ency and 
hyperglycaemia (Yamamoto el aI., 1 98 1 )  Also STZ prevents DNA synthesis i n  
mammalian and bacterial cel l s  (Zagon el aI. , 2006) 
Al loxan ( LX)  i nduced diabetes mel l itus. S ince the discovery of ALX in 1 943 by 
Dunn, Sheehan and McLethie, it is considered the second most commonly used 
compound for i nduction of DM after STZ. ALX is  a uric acid derivative and is  highly 
unstabl e  in water at neutral pH, but stab le  at pH 3 (Srinivasan & Ramarao, 2007) 
ALX act by sel ect ively destroying the pancreatic p-cel ls  result ing in  insu l i n  
defici ency, hyperglycaemia and ketosis ( Rerup, 1 970). ALX exerts its diabetogenic 
action when it is admini stered parenteral ly, intravenously, i ntraperitoneally or 
subcutaneously (Szkudelski ,  200 1 )  I t  has been reported that ALX results in severe 
diabet es which can be equival ent to total pancreatectomy (Etuk, 20 1 0). 
1 . 1 .5.2.3 Spon tan eous Type 1 Diabetic M odels 
There are at l east five animal models under this category: The non-obese diabetic 
mouse (NOD), the Bio-breeding (BB)  rat, the Long Evans Tokushima Lean (LETL) 
rat, the Kom eda diabetes-prone  (KDP) rat and the Lewis (LEW)-IDDM rat The NOD 
mouse and BB rat are by far the most widely used. 
NOD is a known model for T I DM and is a preferred animal model by sci ent ists in the 
study of autoimmune diabetes (Chatzigeorgiou et at. , 2009). I t  was establ ished by 
Makino's group in Japan, from femal e m ice derived from a JcI- ICR strain that 
developed cataracts ( Makino et al. , ) 980). Cl in ical symptoms in the NOD mice are 
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preceded by i n  u l i t i s  which stans at the age of 4-5 weeks, sometime after subcl i n ical 
B-cel l  destruct ion ( hatzigeorgiou et aI., 2009; Mathews, 2005). 
The diabete -prone BB rat IS u ed for studying autoimmune diabetes, it was first 
recogntzed in  the Bio Breeding Laboratories, a commercial breeding company based 
in  Ottawa, in  1 974 (Chatzigeorgiou et al.. 2009, akhooda et aI., 1 977). The BB rats 
pontaneou Iy develop T 1 OM a a result of circulat ing autoantibodies against 
pancreat ic �-cel l s  (Oavenpon et aI. , 1 995) .  After 4 months of age the BB rats develop 
d iabetes characteri stics with severe ketoacidosis (Mathews, 2005) 
The LETL rat was the first di scovered spontaneously diabetic rat model that develops 
autoimmune destruct ion of pancreatic �-cel l s  (Kawano el aI. , 1 99 1 ) . The KDP rat is a 
LETL sub-strain that was estab l i shed as a model that develops the di sease at a very 
high frequency (70%) with no sex difference (Chatzigeorgiou et aI., 2009; Komeda et 
aI., 1 998,  M ordes et aI., 2004). 
1 . 1 .5.3 Experimental Models of Type 2 Diabetes Mellitus 
T20M is  a comp lex and heterogeneous disease currently affecti ng more than 1 00 
m i l l ion people worldwide and causing severe socio-economic impact (Srinivasan & 
Ramarao, 2007) Experimental model s  of T2DM can only represent a few of the 
phenotypes that are found in human T2DM. I t  i s  expected that animal models of 
T2DM are l i k ely to be as compl ex and heterogeneous as the human condition due to 
compl ex interact ion among mult ip le  suscept ibi l ity genes and between genetic and 
environmental factors. The experimental models of T2DM can be classifi ed into. 
spontaneously i nduced, chemical ly  i nduced, d iet i nduced or surgical ly i nduced and/or 
by combination. 
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1 .  1 .5.3. 1 pontaneou or Genetically Derived Type 2 Diabetic Models 
Obe e model s of T2DM The mo t commonly used obese models  for DM are the 
obe e mou e (ob/ob) and the Zucker fatty/fatty ( fa/fa) rats Other models such as the 
diabetic/d iabet ic (db/db )  mouse, The ew Zealand Obese (NZO) mouse, The Zucker 
diabetic fatty rat strai n (ZDF), the Otsuka Long Evans Tokushima Fatty (OLETF) rat, 
and P ammomys obesus are al 0 used 
The ob/ob. Mutation i s  inherited as an autosomal recessive mutation on chromosome 
6 (obese) in C57BLl6J mouse strain, originat ing from the Bar Harbor, Jackson 
laboratory The mutation in ob/ob mice is recognized in the leptjn gene, which codes 
for lept in  ( Srinivasan & Ramarao, 2007) .  The ob/ob mouse shows many of the 
metabol ic  characterist ics by 4 weeks of age, including hyperinsul ineamia, 
hyperglycaemia, obesity and insul i n  resistance ( Dubuc, 1 976). 
The db/db mouse. A receSSive mutant mouse which carnes a mutation on 
chromo orne 4 in mice of the C57BLIKsJ strain The db/db mice have a lept in  
receptor mutation located on the db gene and are spontaneously hyperphagic, obese, 
hyperglycemi c, hyperinsu l inemic, and insul in  resistant within  the fi rst month of l i fe, 
they later develop hypoi nsu l inaemia (Srinivasan & Ramarao, 2007). 
The NZO mouse is a model of polygenic obesity, with rapid weight gain within the 
first 2 months of l i fe. The NZO mouse develops hepat ic insu l in  resistance, 
hyperl ept inemia, l ept in resi stance and hyperphagia (Chatzigeorgiou et al.. 2009, 
Thorburn et al , 2000). 
The OLETF rat was discovered in 1 984 as an outbred colony of Long-Evans rats and 
males which are susceptibl e to develop diabetes later in l ife (Chatzigeorgiou el al.. 
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2009) Animals are characterized by polyphagia, high l evel s  of insul in,  triglycendes 
and chol e terol and progre sive hyperglycaemia (Kawano el aI., 1 992) The OLETF 
rat ha been ext ensively  u ed for testi ng anti-di abetic and anti-hypertensive drugs 
(Chatzigeorgiou el al. , 2009, Harada el aI., 1 999, Ko egawa et aI. , 1 996) 
The Zucker ( fa/fa) fatty or obese rat has an autosomal recessive mutat ion in the fa 
gene on chromosome 5 (Sri nivasan & Ramarao, 2007) It i s  characterized by 
hyperphagia and early onset of obesity, mi ld  hyperglycaemia, insul in  resistance, mi ld 
gluco e intolerance, hyperi nsu l i naemia and moderate hypertension (Durham & Truett, 
2006) Sel ect ive inbreeding of the fa/fa rat for hyperglycaemia resulted in  the ZDF rat 
train, which develops severe diabetes at about 2 months of age due to �-cel 1 
apopto i 
on-obese model s of T2DM. Several animal models have been developed under this 
category includ ing :  the Goto Kak izaki (GK) rat, Torri rat, Non obese C57BLl6 
( Ak ita) mutant mouse and Cohen diabetic rat . 
The GK rat i s  a polygenic non-obese model of T2DM that was establ ished by Goto 
and h is  col laborators through repetit ion of sel ect ive i nbreeding of Wi star rats with the 
highest b lood glucose over numerous generat ions in Japan in  1 973 (Goto, Kak izaki & 
Masalci, 1 976). Thi s model i s  characterized by moderate fast i ng hyperglycaemia, 
hypoinsu l inaem i a  and impaired glucose tolerance which starts early in  l i fe (Portha el 
at., 200 1 ). The GK rat has characteri stic features of DM which are comparable to that 
observed in humans, i ncluding for examp l e nephropathy with thickening of the 
glomerular basement membrane (Shafrir E leazar, 20 1 1 ). The number of pancreat ic 
i s let cel l s  i s  l ess in GK rats at birth, due to defect ive �-cel l prol i feration (Movassat el 
at. , 1 997, Portha et at., 200 1 ). In addition to the defects in �-cel l s, GK rats are 
1 1  
characterized by impaired gluco e- induced insul in secret IOn, hepat ic glucose 
overproduction, and moderate insul in resistance in musc les and adipo e t issues 
( Picarel -B lanchot el al. , 1 996) The GK rat has provided a better understanding of the 
relat ion hip of changes in  �-cel l mass and occurrence of T2DM and diabetic 
compl ication ( r iniva an & Ramarao, 2007). 
Torri rat :  Thi mod el wa establi hed In 1 997 at Torri Pharmaceutical Co, Japan, and 
nam ed the DT (Spontaneously Diabetic Tori i )  rat . I t  is a spontaneous diabetic non 
obe e rat from the Sprague-Dawl ey rat strain It i s  characterized by glucose 
in to lerance, hyperglycaemia, hypoinsul inaemia and hypertriglyceridaemia. The Torri 
model has been used for studying long term DM compl icat ions because they are abl e  
to l ive longer without t h e  need for insul in  t reatment (Shinohara e t  aI. , 2000, 
ri nivasan & Ramarao, 2007) 
1 . 1 .5.3.2 Dietary or N u trition I nduced Type 2 Diabetic Models 
The sand rat, Tuco-Tuco and Spiny mouse are important models of nutrit ional ly 
i nduced obesity and T2DM. 
Sand rat : The gerbi l  p, ammomys obeslis (p .  obesus, Sand rat ) is a natural ly insul in  
resistant rodent with a tendency to develop diet-induced hyperglycemia associated 
with obesity P .  obesus does not exhibit byperglycaemia in  its natural desert habitat, 
feeding on low caloric  vegetat ion. However, when fed regular laboratory chow 
contain ing higher caloric density, the ani mal s develop moderate obesity and 
hyperglycaemia (Kai ser et aI. , 20 1 2) .  
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1 . 1 .5.3.3 Chem ically Ind uced Type 2 Diabetic M odels 
I nduct ion of diabet e  u ing chemicals i s  a common procedure which may explain the 
role of environmental factor affecting the pancreatic insulin ecret ing cel l s  and 
ubsequent developm ent of OM 
Goldthiogluco e (GTG) obese diabetic mouse It i s  well k nown that GTG inj ection 
can induce T2DM Mice i nj ected with GTG are characterized by obesity, 
hyperin u l i naem ia, hyperglycaemia, insul in  resistance within 1 6-20 weeks fol lowing 
GTG inj ection (Le  Marchand-Brustel eL al. , 1 978). The GTG inj ect ion causes a 
hypothalamic l esion which results in  hyperphagia and subsequent obesity i n  
experimental animal model s  (Noguchi e t  aI. , 20 1 2) .  
1 . 1 .5.3.4 Surgically I nduced Type 2 Diabetic Models 
This  method i nvolves compl ete  or partial pancreatectomy In animal s used for the 
i nduct ion of T 1 0M or T2DM, respectively (Srinivasan & Ramarao, 2007) 
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1 .2 T H  H EA RT 
The heart i a hollow muscular organ that pumps blood throughout the bod ' by 
repeated rhythmic contract ions The heart i locat ed in the middle mediast inum 
between the lungs and i enclo ed in the pericardium (Figure ) 1 )  I t  measures about 
1 2  cm in l ength, 8 to 9 cm in breadth at the broadest part It l i es behind the sternum 
and adjoming parts of the rib cart i l ages, and proj ects farther into the left than into the 
right half of the thoracic cavity (Gray, 1 9 1 8 ) 
CROSS-S ECTION OF THE HUMA CH EST 
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http.!/" " "  danddarlmg. m1o/enc,·c1opedJalHlheart html 
Figure 1 1 - Location of the heart 
1 . 2 . 1 A NATOMY O F  T H E  H EA RT 
The wal l s  of the heart are composed of cardiac muscle and it i s  divided into four 
chambers. the r ight and l eft atria and ventricl es The heart l i es obl iquely in the chest 
so that the right ventric le  forms the anterior aspect whi le  the posterior aspect shows 
the left atrium (Malmivuo & Plonsey, 1 995). The left ventricular free wal l and the 
septum are much thicker than the right ventricular wal l  
The heart has four sets of valves Between the  left atrium and ventric le  i s  the  mitral 
valve, and between the right atrium and ventric le l i es the tricusp id valve The 
pulmonary valve l i es between the right ventricle  and the pulmonary artery, whi le  the 
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aortic valve l i e  i th fl n e out ow tract of the l eft ventricl e, control l i ng flow to the aorta. 
(Fi!:,>ure I 2) (Malmivuo & Plonsey, 1 995)  
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Figure 1 . 2 - Cardiac valves 
1 . 2 .2  B LOOD C I RCU LATION 
1 .2.2. 1 Coronary Circu lation 
The Coronary circulation i s  the system that suppl i es the heart with blood The vessel s 
that del iver oxygen-rich blood to the myocardium are known as coronary arteri es The 
vessel s that remove the deoxygenated blood from the heart muscle are known as 
cardiac veins  The coronary arteries have two main branches; the right and the l eft 
coronary artery The right coronary has its origin from the anterior part of the aorta, it 
emerges on the anterior surface of the heart between the roots of the aorta and the 
pulmonary artery and terminates in the wal l  of the l eft ventric le. The right coronary 
artery is the main supp ly of the cardiac conduction system. The l eft coronary 
originates from the l eft posterior sinus of Valsalva, and divides i nto two large and 
more or less constant trunks, the descending and c i rcumflex branches ( Belt, 1 933)  
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] .2 .2 .2  ystemic Circu lation 
The y temic circu lation i s  the system of blood vessel s and associated tissues that 
supp l ie  b lood, and hence oxygen, to the whole body I t  carries oxygenated blood 
from the heart to the body, and returns deoxygenated blood back to the heart (Figure 
1 3 )  The blood returns from the syst emic circu lation to the right atrium and passes 
through the tri cuspid valve to the right ventricl e, where it i s  pumped through the 
pulmonary valve to the lungs Oxygenated blood returns from the lungs to the left 
atriu m, and through the mitral valve it reaches the l eft ventricl e. Blood is  then pumped 
through the aortic valve to the aorta and the systemic circul ation (Malmivuo & 
P lonsey, 1 995)  
1 . 2. 2.3 Pulmonary Circulation 
The pulmonary circul ation is the system which carries deoxygenated blood away from 
the heart, to the lungs, and returns oxygenated blood back to the heart (Figure 1 3 )  
SY STEMIC 
CIRCUIT 
B O DY 
http://lcaVlllgblO netlclfculatof)%20system/clrculatof)%20system htl11 
Figure 1 . 3 - Systemic and pul monary circu lation 
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1 . 2.3 I E RV T I O N  O F  TH E H EA RT 
The heart i s  control l ed by the autonomic nervous system, which compnses the 
ympathetic and parasympathetic nervous systems These two opposing system 
balance each other and maintain the steady state of the heart The sympathetic 
inner ation of the heart consists of nerves that arise from the thoracic and lumber 
p ine and synapse with the nervous t issue of the heart, which i s  known as the cardiac 
p ie  u The nerve of the cardiac plexus serve as a conduit through which certain 
neurotransmitters such as norepinephrine  and acetylchol ine can travel to reach their  
target receptors i n  the heart The sympathet ic nervous system has a wide diversity of 
cardio ascular actions, such as i ncreasing heart rate and cardiac contracti l ity, reducing 
enous capacitance and constrict ion of resistance vessel s On the other hand, the 
parasympathetic nervous system does the opposite through vagal impulses. The vagus 
fibers conn ect to the atria and the superior portions of the ventricles The rel ease of 
neurotransmitters from the vagus nerve results i n  a decrease i n  heart rate and 
contract i l ity. 
1 . 2.4 ME C H A N ICAL P HY S IOLOGY OF T H E  H EA RT 
Cardiac muscle i s  a type of i nvoluntary striat ed musc le  found in  the wal l s  and 
myocardium of the heart . The cel l s  that comprise cardiac musc le  are called 
cardiomyocytes and they are nucl eated The wal l  of the human heart is composed of 
three layers The outer protective layer i s  the epicardium; the midd le  muscular layer i s  
t h e  myocardium which contracts. The inner layer i s  the endocardium which i s  
i n  
contact with t he  b lood that the heart pumps and is  continuous with the inner l
i n ing of 
blood vessels .  
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1 . 2 .5  E L ECTRICA L PRY IO LOGY O F  T H E  H EA RT 
The heart contract teadi ly to pump blood throughout the body I n  the mammal ian 
heart thl  coordi nated contraction of the atrial and ventricular muscle i due to the 
preci e In i t iation and transmission of action potent ials through a specialized t issue 
net work, known as the cardiac conduction system which can be divided i nto the 
i mpulse generat ing nodes and the i mpulse propagating His-Purk inje  system (Park & 
Fi hman, 20 1 1 )  The main components of the cardiac conduction system are the SA 
node, AV node, bundle of  H i s, bundle branches, and Purk inj e  fibers (Figure 1 4 )  
http://b�Tonroberts \\ ordpress comJtagiheartl 
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Figure 1 4 - Cardiac conduct ion system 
The conduction system comprises ion channels (Kaupp & Seifert, 200 1 ), channel ­
associated proteins (Kupershmidt et al. , 1 999), connexins (Gros & Jongsma, 1 996) 
and t ranscriptional regulators (Kaupp & Seifert, 200 1 ) . 
1 . 2 .5. 1 S inoatrial N ode 
The sinoatrial node ( SAN) i s  a heterogeneous t i ssue implanted in  the right atrial wal l 
near the open ing of the superior vena cava These cel ls  are modified cardiomyocytes. 
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They po e rudimentary contract i le fi laments, but contract relativel weakly 
Pacemaking i mpul es are spontaneou Iy generated by AN cel l s  Since they display 
the most rapid intr in ic rate of excitat ion, the SA cel ls  function as the "pacemaker" 
of the heart (Takashi ,  2007). 
1 . 2 .5.2 Atrioventricular Node 
lllce the di covery of the A VN by Sunao Tawara in 1 906, A VN structure and 
function became an i mportant area for research study. The A VN is located at the 
center of Koch' Triangle - a triangle enclosed by the septa] leaflet of the tricuspid 
valve, the coronary sinu , and the membranous part of the inter-atrial septum (Figure 
I 5 )  
A'l/ ,... ... 
http.//\\\\"\\ ncbl nlm mh.gov/pmc/artlcles/PMC3572393/ 
Figure 1 . 5 - Koch's Triangle 
The A VN not only transmits the pacemaking impulses from the
 SAN to the 
ventricu lar myocardium but a lso slows the transmi ssion of impul
ses from the atrial to 
the ventricular muscle. This  delay al lows complete blood eject
ion from atria to the 
ventricles Moreover the A VN acts as a backup pacemaker 
in  the case of S AN fai lure. 
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Various molecular mechani sms have been suggested for thJS conduct ion delay. For 
exam ple, the structural arrangement of the nodal cel l s  a a multi-layered structure 
may delay conduction A lso, small cel l si ze, abundant connective ti ssue separat ing the 
A nodal cel l  , Ie ser expres ion of a channels and poor electrical couplmg 
between these nodal cal l s  may contribute to the delay process (Temple et al. , 20 1 3 ) . 
1 .2 .5.3 Rapid I m pulse Conduction 
The pacemak ing impul ses t ravel from the S AN to the A VN, from where they wi l l  be 
tran mitted to the ventricular conduct ion network which includes the A V -bund le , 
bundle branches and Purk inje fibers Thi s conduction network functions mainly to 
propagate and transmit impul es rapidly to the ventricular muscle. These two bundle 
branches, left and right continue as Purki nje fibers. Purk inje fibers are distributed 
widely throughout the sub-endocardium of both ventricles (Figure 1 4). The mai n 
funct ion of the ventricular conduct ion network is  to rapidly propagate and transmit 
impulses to the ventricular muscle. Moreover, gap junctions electrical ly couple the 
t ips of Purk i nj e  fibers to muscle cel l s, thus introducing an apex to base contract ion of 
the ventricle (penn isi el al. ,  2002) 
1 . 2.6 T H E CA R D I AC ACTION POTENTIAL 
Cardiac electrical act ivity i s  normal ly in it iated and spread in  an orderly fashion. This 
spontaneous generat ion and propagation of electrical act ivity is mainly as a result of 
changes i n  ionic concentration. Act ion potentials of non-pacemaking myocytes are 
sometimes referred to as the "fast response" action potentials. These act ion potentials 
have a true resti ng potential (Cr r Pharmacology: Cardiac Action Potentials, 20 1 3 ). 
The cardiac action potential has five phases as shown in (Figure 1 . 6). In phase 4 the 
rest ing membrane potential i s  very negat ive (-90 mY). This i s  produced mainly by the 
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opening of pota ium channels al lowing positIve K ions to leave the cel l along the 
concentration grad ient for K (h) that exi ts  across the cel l membrane. Phase 4 i s  
fol lowed by  a tran ient increase in  fast sodium channel conductance (l':-'a) through fast 
a channels  which rapidly depolarizes the e cel l s  (phase 0) to a threshold voltage of 
about -70 m V (e g . ,  by an action potential in an adjacent cel l), meanwhi le, K 
channels clo e During phase 1 ,  there is an I nitial rapid repolarization as a 
consequence of the rapid voltage-dependent inactivation of l""la and the activation of 
If...to Pha e 2 is characterized by increase in  membrane permeabi l ity to Ca2 giving rise 
to the plateau phase of the cardiac action potential (lea.!), which maintains  
depolarizat ion and prolongs the act ion potential Ca2 channels inact ivate during the 
plateau phase. K
+ channels then open and K current flows out of the cel l producing 
repolarization in phase 3 ( Li & Dong, 20 1 0; Pinnel l  ef aI, 2007). 
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Figure 1 6 - Ventricu lar action potential 
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1 .2 .7  T H E PAC E M A K E R  POTE TIA L 
The pacemaker potential i s  characterist ic of the S and A nodal cel l s  n l ike the 
AP of cardiac myocyte , the pacemaker AP lacks phases I and 2 and also pacemaker 
cell do not have a table re t ing membrane potent ial The SA nodal action potent ial s 
are diVIded into three phase (Figure 1 . 7 )  At the end of repolarization, when the 
membrane potential is very negative (about -60 mY), Na ion channels open that 
conduct 10 , inward (depolarizi ng) a currents ( I r) These depolarizing currents 
cause the membrane potential to begin to spontaneously depolarize, thereby init iat ing 
Phase 4. Thi pontaneous depolarizat ion of the pacemaker potential gives the heart 
its auto-rhythmicity When the membrane potential reaches -50 mY, a transient type 
(T-type) of Ca2 channel opens which al lows Cali- conductance (ICa,T) and more 
depolarization (-40mV), th is  is fol lowed by openi ng of another type of Ca2
+ 
channel 
cal led long-l ast i ng or L-type Ca2+ channels. Opening of these channels causes more 
Cal to enter the cel l ,  further depolarizing the cel l and triggering the act ion potential 
once the membrane potential reaches t hreshold between -40 and -30 mY. Phase 0 is 
the depolarization phase of the action potential which i s  primari ly caused by increased 
Ca2 conductance through the L-type Ca2
+ channels (lCa,L) , as both T-type Ca2'" and 
a channe ls  are closed at th is  stage. This is fol lowed by phase 3 repolarizat ion, 
where K channe ls  open thereby i ncreasing the outward directed, hyperpolarizing K
+ 
currents  ( lK) At the same t ime, the L-type Ca
2+ channel s become inact ivated and 
close. Once the cel l  i s  completely repolarized at about -60 mY, the cycle i s  
spontaneously repeated (CV Phamzacology: Cardiac ActIOn Potentials 20 1 3 ; Pinne l l  
et al. , 2007). The changes in  membrane potent ial during the d ifferent phases are 
brought about by changes in  the movement of ions 
22 
+ 3 0 
I K  
0 
> 
E 
- 3 0 
-60 
httpJ/\" ,,, C\l)hysiolog\ comJArrh\,thmia"-'A004 htm 
Figure I 7 - Pacemaker potential 
1 . 2 .8  G E N E RA L  P RO P E RT I ES OF CA R D I AC ION C HA N N E LS 
The generat ion of an act ion potential i n  the heart is the result of the selective 
penneabi l i ty of ion channels di stributed in the cell membrane. Ion channel s have 2 
major properties, ion permeation and gating (Hi l l e, 1 984). 
Ion permeat ion describes the movement through the open channel .  Gat i ng is  the 
mechanism of opening and closing of ion channels .  Ion channel s are sub-classified by 
their mechanism of gat i ng into : voltage-dependent, l igand-dependent, and mechano-
sensitive gati ng (Grant, 2009) 
1 . 2.8. 1 Sod iu m  Chan nels 
The human cardiac sodium channel is a member of the fami ly of voltage-gated 
sodium channels. The channel consi sts of a primary a and mult iple secondary p 
subunits  (Figure 1 . 8) .  The a subuni t  generates sodium current, whi le the role of the p 
subunit of  the cardiac sodium channel has not been establ i shed The p subunit of the 
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neuronal odium channel, Increa es th I 1 f e eve 0 expressIOn and alters the gat ing 
(Grant, 2009) 
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Figure 1 9 - Structure of sodium channel with a. and � subunits (Abriel, 2007) 
1 . 2.8.2 Calc ium Chan nels 
In the heart Ca2+ is the core intracel lu lar signal i ng ion Voltage-dependent calcium 
channels are formed as a complex of several d ifferent subunits. 0.[ ,  0.26, � [ -4, and "( 
(Figure 1 . 9) .  The a. ]  subunit forms the ion conducting pore whi le the associated 
ubunits have several fu nct ions including modulation of gat i ng. The 0.26 gene forms 
two subunits ' 0.2 and 6, they are l i nked to each other via a disulfide bond. Co-
expression of the 0.26 enhances the level of expression of the 0.1 subunit and causes an 
i ncrease i n  current ampl itude. The 0.26 subunit i s  a binding site for at  least two 
ant iconvu l sant drugs, gabapent i n  and pregabal in .  The intracel Jular � subunit i s  
hypothesized to have a major role in  stab i l iz ing the final 0. 1  subunit conformation and 
delivering it to the cel l  membrane, therefore the � subunit functions init ial ly to 
regulate the current density by control l ing the amount of a.] subunit expressed at the 
cel l membrane (Bichet ef al. , 2000). Eight genes encode the "( subunit proteins. The "( 1  
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subunit doe not affect trafficktng, and is  not required to regulate the channel 
complex. However, "(2, "(1, "(4 and "(8 are al so associated with AMP glutamate 
receptor in neuronal cel l s  
oltage-dependent Ca2 channel s are respon ib le  for Ca2 influx secondary to 
membrane depolarization Ca2 regulates excitation-contraction coupling (ECC), 
hormonal ecret ion and possibly gene transcript ion In the cardiac muscle there are 
two disti nct Ca2 channel L-type and T -type Ca2+ channel s The L type Ca2 � 
channel are the most abundant channel in  cardiac muscle cel l s  and are characterized 
by high voltage acti ation. The T -type Ca2 channel s are characterized by low voltage 
activat ion, and are found mainly i n  pacemaker, atrial, and Purk inje cel l s  (Bean, 1 985 ;  
i l i u  el  al. , 1 985)  
b 
II III IV 
ooc 
Figure 1 . 9 - Structure of voltage dependent calcium channel with several different 
subunit s a i ,  a2D, � 14, and "( (a) and the structure of al subunit which form
s the ion 
conducti ng pore (b) ( Lacinova, 2005)  
1 . 2 .8.3 Potass ium Chan nels 
KT channel s are formed of pore-forming a-subunits and �-subu
nits (Coetzee et aI , 
1 999' N i l ius  et aI. , 1 98 5 ,  Snyders, 1 999) Key features of 
a-subunits are. (a) a pore 
) 
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region that al low K Ions to flow across the p lasma membrane, (b) a select ivity fi lter 
that allow K but not other ion to cross the pore, and (c) a gat ing mechani sm that 
control witching between open-conduct ing and closed-non conducting states and 
determines whether permeat ion occur in response to either changes in membrane 
potential or a l igand K channels have been classi fied into three major fami l ies on the 
ba i of the primary amino acid sequence of the a.-subunit (Coetzee et aI., 1 999; Shieh 
ef 01 , 2000, nyders, 1 999) 
J - Channels contain ing SIX trans-membrane segments and one pore-forming 
region (Figure 1 l Oa) Thi s  architecture is typical of Kv channels The a. subunit of Kv 
channel have s ix  t rans-membrane-spanning segments (S  I -S6) with  cytoplasmic N­
and C-terminal domains  and a pore region responsible for K+ ion conduction and 
select ivity 
2- I nward rectifier K+ channels (K.r) contain two trans-membrane domains (M l 
and M2)  connected by a pore and intracel lu lar N- and C-termini  (Figure 1 . 1  Ob) Thi s 
architecture is typ ical of K 1 ,  K-Hp and K-\ch channels (Lopatin & Nichols, 200 I ;  Mark 
& Herlitze, 2000; Nerbonne, 2000) .  They conduct K currents more in the inward 
direction than the outward and play an important role in sett ing the rest ing potential 
close to the equi l ibrium potential for KT and i n  repolarizat ion (Seino & M iki, 2003 , 
Shieh el al , 2000; Snyders, 1 999) 
3 - Four trans-membrane segments and two pore channels (K2P) have intracel lular 
- and C-termin i  (Figure l . 1 0c)  This form of K channels plays a role in regulat ion of 
rest ing membrane potential and excitabi l ity ( Lesage & Lazdunski, 2000; Patel & 
Honore, 200 1 ). 
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L __ H COo-- _ .:;:, 
Figure 1 1 0  - Schemat ic representations of (a) the six-transmembrane one-pore-region 
voltage-dependent K -channel, (b) the two trans-membrane one-pore-region inward-
rect ifying K channel (K,r), and (c) the four-transmembrane two-pare-region K 
channel ( K2P) responsible for ' leak' K currents  (Giudicessi & Ackerman, 20 1 2) .  
1 .2.9 EXC ITAT I ON-CONTRACT ION CO UPLING 
Excitation-contraction coupl ing ( ECC) i s  the  process of conversion of  an  electrical 
stimulus to a mechani cal response. The second messenger Ca2
• 
plays a major role in  
ECC (Bers, 2002).  When a myocyte i s  depolarized by an action potential, Ca2+ enters 
the cel l  through L-type Ca2 channels located in the plasma membrane as i nward Ca2
+ 
current (Ica.d (Figure 1 1 1 ) However i s  not itse lf used to directly cause contraction 
Only about 1 0% of th is  Ca2 contributes to contraction of the muscle I nstead it 
triggers Ca2 release from the sarcoplasmic reticulum (SR) through ryanodine 
receptors, which raises the free intrace l lu lar Ca2
+ 
concentration from about 1 0"
7 
to 1 0" 
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SM, al lowing the free Cal
' 
to b ind to the myofilament protein troponin C (TN-C) 
When Cal
+ 
binds to the TN-C, this i nduces a confonnat ional change in  troponin-I 
(TN- I )  exposing the binding site of the act i n  molecule to b ind to the myosin head 
Thi binding resu lts in ATP hydrolysis that yields the energy required for 
confonnational changes to occur i n  the act i n-myosin complex The result of these 
change is a movement ( lt ratchetinglt) between the myosin heads and act i n, result ing 
in  shorten i ng of the total sarcomere length . For relaxat ion to occur Ca2+ must decl ine 
al lowing Ca2 to dissociate from troponin This requires Ca2 transport out of the 
cyto 01 by four pathways involving SR  Ca2
+ 
-ATPase (SERCA, sarco-endoplasmic 
reticulum calcium-ATPase) which removes 70% of the activator Ca2
+
, sarcolemmal 
a ICa2 exchange removes 28%, sarcolemmal Cal -ATPase and the mitochondrial 
2 . 0/ f Ca2+ (C r '  Ca uniport, where both together remove the remainmg 21'0 0 � 
Pharmacology: Cardiac Action Potentials, 20 1 3 , Bers, 2002) .  
Vo tllge-galed 
Ca channel Sarcolemma 
Ca·· 
....... ",-
NCX 
/ 3Na' 
3Na' 2K' 
1 / \ I 
ATP NCX ATP 
\ I \ 
3Na' 
..  ' .. 
... Contraction 
200 ms � I 
Figure 1 . 1 1  - Excitation-contraction coupling (Bers, 2002) .  
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CHAPTER 2 
AIMS AND OBJECTIVES 
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2 1 M  D OBJ ECTIVE 
A mentioned prevIOusly, d iabetes i s  currently the fastest growing disease in  the 
world . The est imated global prevalence of DM is  around 382 mi l l ion diabetic people, 
and the number of people with the di sease is set to rise beyond 592 mi l l ion by 203 5 
(Dlaheles A lIa In/emallOnal Dlahetes Federation 20 1 3 ) The UAE is ranked 1 5th 
worldwide, with 1 8  98°'0 of the AE population l iving with diabetes, with 25% of the 
population being affected by the di sease, particularly T2DM (Diabetes A lIas 
IntematlOna! Diabetes Federation 20 1 3 , 'Diabetes Facts' 20 1 4; E I-Sharkawy 2009, 
20 1 2 , I phigenia 2009) This  represents a huge cost to society in terms of morbidity 
and mortal ity Mortality l inked to DM constitutes 75% of deaths among UAE 
nat ionals and 3 1  % among non-nationals (Janlio/Y 2009 - Middle East Update, 2009). 
The cardiovascular changes are considered the most prevalent adverse risk associated 
with DM and are l i nked to an i ncrease in mortality rate (Movahed et al. , 2005) I n  
addit ion to an  i ncreased ri sk of  heart attack and stroke, cardiac electrical 
abnormal it ies are commonJy observed. These include various arrhythmias (Lindstrom 
et 01. , 1 992), AV block (Movahed, 2007; Movahed et al , 2005), a prolonged QT 
i nterval,  and sudden cardiac death 
The consumption of sugar-sweetened beverages has been l inked to rising rates of 
obesity Sucrose is found in considerable  quantities in many fizzy drinks and other 
types of widely consumed beverages (Sartorel l i  & Cardoso, 2006). Experimental 
studies have demonstrated that consumption of sucrose-enriched diets can cause 
insul in  resistance, hyperl ipidemia and i ncreased fat deposit ion in the heart (Howarth, 
2004) 
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The GK rat i s  one of the be t characterized genet ic animal model s  of T2D�1 
variet of contracti le  dysfunctIons have been demon trated in the GK rat heart 
i ncluding decreased heart rate, decreased eject ion fraction and prolonged t ime-course 
of horten ing and/or relaxat ion in ventricular myocytes and some of the e defects 
have been attributed to defect in calcium transport (Howarth et aZ. , 2008, Howarth & 
Qure h i ,  2008 ,  Howarth el af. , 2007; l i t i s  ef al.. 2005)  The consumption of sugar-
weetened beverages ha been l inked to rising rates of obesity which in  turn i s  a risk 
factor for development of T2DM 
We hypothesize that feedi ng GK rats a sucrose-enriched diet wi l l  modify the t ime 
cour e for the development of DM which in  turn wi l l  be associated with further 
deteriorat ion of heart funct ion.  The ai m of the study was to investigate the effects of 
ucro e-enriched diet on ventricular myocyte shortening and Ca2+ transport in GK 
T2DM rats, as wel l as expression of genes encoding various cardiac muscle proteins 
The specific a ims  of the project were· 
• To estab l i sh the experimental model and monitor the effects of a sucrose­
enriched diet on body weight, blood glucose, feed ing and drink ing habits i n  
GK and Control rats 
• 
• 
• 
To i nvestigate effects of a sucrose-enriched diet on ventricular myocytes 
shortening in GK and Control rats 
To i nvestigate effects of a sucrose-enriched diet on Ca
2+ transport 1 0  
ventricu lar myocytes i n  GK and Control rats .  
To i nvest igate effects of a sucrose-enriched diet on expreSSIOn of genes 
encodi ng a wide variety of cardiac muscle proteins i n  ventricular t issue from 
GK and Control rats 
31  
CHAPTER 3 
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3. M ET H O D  P R R I  CI PLE 
3. 1 TH E L GE DORFF H EA RT P R E P A RATIO A D ISOLATIO OF 
V E N T R I C U LA R  MYOCYTE 
The u e of ani mal models to study our body systems has contributed significantly to 
our under tandi ng of di  ea e pathogenesis, improving our diagnostic techniques and 
moreover, the development of more effect ive and specific prevent ive and therapeut ic 
procedure , whether pharmacological or i ntervent ional . I n  the mid-nineteenth century 
Carl Ludwig was the first physiologist to systematical ly study i solated organs (heart, 
mu cle, k idney, l iver, and lung) Later i n  1 866, El ias Cyon estab l i shed the i solated 
perfu ed frog heart preparation at the Carl Ludwig I nstitute of Physiology in Leipzig, 
Germany This  preparation was subsequently subj ected to various modifications and 
revision (Zi  mmer, 2000), and later it was establ ished by Oscar Langendorff in 1 897 
Observat ions made using these methods led to important discoveries, forming the 
basis for our understanding of heart physiology, which includes the role of 
temperature, oxygen and calcium ions for heart contracti le function, the origin of 
cardiac electrical activ i ty in the atrium and the negative chronotropic effect of vagus 
stimulat ion and many other parameters (Skrzypiec-Spri ng et aI. , 2007). 
The langendorfT system compri ses a thermostat control ler, peristalt ic  pump, water­
jacketed reservoirs fi l l ed with physiological solutions and heat exchanger (Figure3 1 )  
The advantages of th is  preparation are the reasons for the method's longevity: 
s impl i city of the preparat ion, low cost, reproducib i l ity and the abi l ity to study the 
organ in  i solation of other organ systems and exocrine control that may confound 
physiological measurement (Bel l  e( al. ) 20 1 1 ). Moreover, it al lows a broad spectrum 
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of b iochemica l ,  phy iological , morphological and pharmacological indice to be 
measured (Pracflcal Method .. 111 Card10vasclIiar Research, 2005) 
Reservoirs 
containing 
physiological 
solutions 
Thermostat 
control ler 
, 
- - - - - - � 
-
Heat 
exchange 
Peristaltic 
pump 
Perfused 
heart 
Figure 3 1 - The Langendorff perfusion system ( Prof. Chris Howarth 's  laboratory) 
H eat 
exchanger 
a 
- - - -� 
cannulated 
heart 
- - - '-----� 
F igure 3 2- Close up photograph of the heat exchanger(a) and the cannulated heart(b) 
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3.2 V I DEO E DG E  DETECT IO 
Tn e lectrophysiology, the edge detection system is u ed to detect the changes in cel l 
length, width or shorten ing by sensing left and right cel l boundaries using a thre hold 
( teadman el aI , 1 988) This method 1 widely used in research experiments to study 
ani mal and human cardiomyocyte Cardiomyocytes are characterized by irregular 
edge due to the pre ence of gap junct ions, mUlt i p le intercalated disks, and variable  
cel l  widths, which can  make the  appl icat ion of  the edge detection system on  the 
cardlOmyocyte d ifficu lt ( Delbridge & Roos, 1 997) .  Video edge detection system 
consi sts of a high speed video camera (Myotrac, Crystal Biotech, UT, USA) an analog 
dual-edge detector ( VED- 1 1 4, Crystal Biotech, USA), a data logging device (CED-
1 40 1 +, Cambridge Electronic Design, Cambridge, UK), a PC and a monitor The 
principle of detection of the edge of the cardiornyocyte is  the dark/l ight or l ight/dark 
i nterface and detect ion of myocytes contraction rate by the increase or decrease of the 
d istance between the two cursors over the cel l boundaries (Figure 3 . 3 )  The distance 
between the two edges is measured using edge detection whi le a record of the data is  
stored on the PC (Bazan et aI, 2009) . This system i s  able to record up to 240 length 
measurements per second A standard microscope stage graticule is used to cal ibrate 
the signal Right VIdeo edge cursor 
Figure 3 3 -Ventricular myocyte with video edge cursors across the two ends of the 
cel l  The cel l  is purposely out of focus to improve cel l end contrast. 
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3.3 FLUO R E  C E NC E  PH OTO M ETRY 
Fluore cence 1 a molecular phenomenon in  which a substance radIates l Ight energy 
almost in tantaneously upon being truck with l ight from another source orne 
energy from th is  incident l ight i ab orbed by this substance, meaning that the 
radiated l ight is typ ical ly of lower energy (and thus longer wavelength) than that of 
the ource The process of l ight absorption and radiation is known as excitation and 
emission ( The Fluore \'cence Phenomenon Chroma Technology, 20 l 3 ) The photon 
that excites the dye always has a smal ler wavelength than the photon that gets 
emitted F luorescei n-ba ed dyes for example, get excited at a wavelength around 500 
nm, which is b lue l ight, but emit at around 530 om, which is green l ight (Figure 3 4) .  
Dyes do not get excited at a single di scrite wavelength, but by a range of wavelengths 
around a peak, the excitation spect rum. The same i s  true for etlli ssion, there i s  an 
emi sion spectrum, characterized by a peak in  the spectrum Companies that sel l 
fl uore cent dyes usual ly provide the excitation and emission spectra (Fluorecence, 
20 l 3 ). 
http //www . chroma.comlknowledge/introduction-fluorescence/fluo
rochrome-spectra 
Figure 3 4 - Excitation and emission spectra for a fluorescent dy
e 
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Fura-2 i a polyamino carboxyl ic acid, a rat iometnc and sensit ive fluore cent 
indicator dye whIch bi nds to free intracel lular calcium (Grynk iewicz et aI. , 1 985)  
Acute i ncrea e or decrease f F 2 d . o ura- ye Intensity reflect a change in Ca2 
concentration ( Bootman el al.. 20 1 3a) I n  the case of fura-2 the excitation l ight i 
alternated rapidl between 340 and 380 nm The Ca2
1
-free form of Fura-2 has a peak 
excitat ion wavelength of -380 nm, whereas the peak excitat ion wavelength for Ca2 _ 
bound Fura-2 i s  --... 340 nm (Figure 3 5 )  (Bootman ef aI , 20 1 3b) .  The emitted l ight i s  
mea ured at around 5 1 0  nm 
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http://\\ '\\\\ . h fetechnologles comJae/en/homelhfe-sclence/drug-dtscovery/larget -and-lead-identi fication-and­
valldauonlg-protem-coupled-htmllcell-based-second-messenger-assaYsifura-2-calclwn-inrucator hunJ 
Figure 3 . 5  - Fluorescence excitat ion spectra of fura-2 in  solut ions contain ing 0-39 8 
11 M  free Ca2 . 
F luorescent Ca2
1 
indicators have carboxyl ic acid groups for bindi ng of Ca2+. Because 
these "free-acid" forms of the ind icators are hydrophi l ic, they cannot readi ly cross cel l  
membranes and need t o  be introduced into cel ls  using some techn iques such as 
microinjection, p inocytosis, or diffusion from a patch pipette. However, the most 
convenient and widely used method for loading indicators into cel ls  is as hydrophobic 
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compound I n  which the carboxyl ic  acid groups are e terified (commonly a 
acetoxymethyl [ M]  or acetate esters) The ester forms of the indicators are able to 
permeate the pia rna membrane The Ca2 -sensitive, free-acid  form of the indicator is  
l iberated fol lowing hydrolysis of the ester groups by intracel lu lar esterases This turns 
the Fura molecule i nto a salt that i trapped in the intracel lu lar compartment (Loading 
Fura-2 into cardlOmyocytes, 20 1 4) As Ca2 i ndicators are l ight-sensitive, most steps 
are performed in reduced l ight (Bootman el aI. , 20 1 3b) .  
I maging fluorescent Ca2
+ 
i ndicators with in l ive cel l s  can be readi ly  achieved using a 
fair ly modest setup. A basic wide-field system compri ses of a research-grade 
m icro cope (typi cal l y  i nverted), an intense broad-spectrum l ight source, appropriate 
m i rrors and fi lters to separate excitation and emission l ight, a suitable objective lens, 
and a camera (Figure 3 6) ( Bootman et aI. , 20 1 3a). The l ight is transmitted from the 
l ight ource via a l iquid l ight guide and various m irrors and oi l  objective to the fura-2 
loaded cel l s  F luorescent molecules absorb only at specific wavelengths therefore a 
fl uorescence microscope must have a l ight source able to produce various 
wavelengths for excitat ion. Having a xenon arc lamp or mercury-vapour lamp that 
generates white l ight, which is a mixture of al l v is ib le wavelengths, usual ly solves this 
problem special optical fi lter cal led an excitation fi lter removes any other 
wavelength of l ight other than the wavelength used to excite the fluorescent molecu le. 
The next element i n  t he optical pathway i s  cal led a dichroic mirror, which is a special 
mirror that is able  to reflect certain wavelengths  of l ight and let other wavelengths 
pass through When the fi ltered wavelength exi ts  the excitat ion fi lter, it gets reflected 
onto the sample contain i ng the fluorescent molecules. This leads to the absorption of 
photons and the emission of photons of a shorter wavelength. Because the emitted 
photons have a shorter wavelength than the absorbed photons, t he design of the 
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dichroic mirror pennits them to pas through the dichroic mirror onto the ocular or 
detector y tem of the mIcro cope The emission of l ight is collected by the detector 
(photomult ipl ier tube) and appropriately f dtered and ampl ified I n  the case of Fura-2 
the emi ssions ( 340 and 380 nm)  and the Fura-2 ratio are typically stored and 
di p layed by a PC (Fluorescence f1l1croscopy: SCience JI1 your eyes, 2008) 
Detector 
Emmis[on fi lter 
£)(cI�tlon filtlH' 
Ligth sourc!! 
Objective 
Fluorescent labelled cell 
http'//w\\,\\ SClenceUlyoureyes comfmdex phP')ld=79 
Figure 3 6 - Fluorescence microscope 
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3.4 POLY M E RA E C H A I N  REACT ION 
The polymera e chain reaction (peR)  i s  an lI1-vilro method for producmg large 
amount of specific DN or RNA fragments of defined length and sequence from 
small amounts of short ol igonucleotide flanking sequences (primers) The reaction i s  
efficient, specific,  and extremely sen i t ive (Polymerase Cham Reaction - MeSH _ 
NCB!, 20 1 3 ) The peR technique wa developed by Kary Mul l i s  i n  1 983, i n  which a 
ample of chromosomal DN A, al 0 cal led genomic DNA can be used as a start ing 
material for a peR With peR, the i nvestigator can ampl ify a single copy of D A 
egment i nto m i l l ions of ident ical copies ( The Polymerase Chain ReactIOn, 2006). 
peR is now a common technique used in  medical and biological laboratories for a 
variety of app l i cat ions i ncluding, DNA cloning for sequencing, DNA-based 
phylogeny, or functional analysi s of genes; the diagnosi s of hereditary di seases; the 
identificat ion of genet ic  fingerprints and the detection and diagnosis of infect ious 
diseases (Saik i  el aI. , 1 988 ;  Saik i  ef aI. , 1 985) .  
The PCR reaction req u i res the fol lowing components and reagents:  
DNA template ·  the sample D A that contains the target sequence. (Figure 3 .7a,b) 
a b 
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Free nucleotide the e sent ial c 
"bui ld ing b lock " for new 0 A 
trand (Figure 3 7c) 
o primer The pri mer are single-
tranded 0 that i typical ly 20 
nucleotide long and complementary 
111 equence to the end of the target 0 A (Figure 3 7c) 
o A polymerase: a type of enzyme that synthesizes new strands of DNA 
complementary to the target sequence (Figure 3 . 7c) Taq DNA polymerase i s  the most 
commonly u ed enzyme, it can tolerate the intense heat of the peR react ion (from 
I1JeI'l11l. aquallcus), however, Pfu DNA polymerase (from PyrococclIs jzmosus) i s  
a lso widely used because of  its higher fidel ity when copying DNA. 
peR reaction genera l ly  consists of a 
eries of temperature changes that are 
repeated 25  - 40 t imes or cycles A 
cycle begins  by heating the reaction 
mixture to 95 °C (Figure 3 . 7d); the 
heat denatures the hydrogen bonds that 
hold the strands together 
After denaturing the DNA, the 
temperature i s  reduced to around 60 
°C (Figure 3 7e), so that the primers 
can form hydrogen bonds or anneal 
with their complementary sequences 
in the target DNA 
d 
9S · C  
e 
.. 
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f 
l n  the next pha e, the temperature is Polymeriu DNA 
raised to 72 C (Figure 3 . 7f), Taq 
polymera e functions optimal ly at this 
T c 
temperature and begin 
polymerizat ion, add ing nucleot ides to 
each pri mer in  the two strands, after g---------�-_____ .....J 
one complete cycle, there are two 
double stranded copie of the target 
D (Figure 3 7g). 
The PCR reaction next cycle contains  
many copies of primers and an  
addit ional supply of nucleotides to 
perform many addit ional cycles 
(Figure 3 7h)  After a second cyc le  
there are four copies of target 
D A., with each addit ional cycle the 
number of copies of target sequence 
doubles 
At the end of cycle 25 ,  there are more 
than 33 m i l l ion cop Ies of double 
stranded target DNA regIOn (Figure 
3 7i) (Probe, Reagent jor junctional 
Genomlcs (peR), 20 1 3 ) 
2 Copies ofTarget DNA Cycle 1 
h 
... 
http: \"w\\ .sumanaslOc com \\ebconten! arumatJons conteot p 
cr html(Probe, Reagents /or foncllonal Genol1/1cs (peR) 
20 1 3 )c prob<! doc TechPCR. shtml 
Figure 3 . 7  - Schemat ic drawing of the PCR cycle. 
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Figure 3 8 - Model of real t ime quanti tative peR plot 
Rever e Transcript ion PCR (RT-peR)  i s  for ampl ifying DNA from RN A RT-PCR 
re er e transcribes RNA into cD A, which is then ampl i fied by PCR 
quant itat ive polymerase cha in  react ion (qPCR), also called real-t ime peR, is a 
laboratory technique of molecular bio logy used to ampl i fy and simultaneously 
quantify a targeted DNA molecule For one or more specific sequences in a DNA 
sample, quantitative PCR enables both detection and quant ificat ion The procedure 
fol lows the general principle of polymerase chain reaction; its key feature is that the 
ampl ified DN A is detected as the reaction progresses in "real t ime", rather than being 
detected at the end of the process as in the standard peR technique. The real-time RT-
peR uses fluorescent reporter molecules such as TaqMan, to measure the amount of 
ampl ified product i n  real t ime, where the fluorescence from the ampl ificat ion reaction 
is proportional to the amount of amplified product (Figure 3 . 8 )  (Bustin et aI., 2005) 
Reverse transcript ion fol lowed by quant itat ive polymerase chain reaction analysis has 
become the method of choice for the detection of mRNA as it is an extremely 
sensit ive and cost-effect ive method ( Bust in 2000; Udvardi et aI. , 2008). 
The two most commonly used methods to analyze data from real-t ime, quantitative 
peR experiments are absolute quant ification and relative quant ification. Absolute 
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quant ificat ion determines the input copy number, usual ly by relat i ng the PC R  signal 
to a standard curve Relat ive quant Ification rel ates the PCR signal of the target 
transcript in  a t reatment group to that of another sample such as an untreated control 
(Livak & chmittgen 200 I )  The deIta-delta-Ct or LlLlCt algorithm, i s  a convenient 
method to analyze the relat ive changes in gene expression. I t  requires the assignment 
of one or more housekeeping genes, which are assumed to be uniformly and 
con tantly expressed in al l  amples, as wel l as one or more reference samples (Livak 
& Schmittgen, 200 1 ,  Zhang JD, 20 1 3 ) 
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METHODS AND MATERIALS 
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4. 1 ET H O D  D M A T E R I A L  
4. 1 E PE R I M ENTA L  PROTOCOL 
V E  T R I C U LA R  M YOCYTES 
4. 1 . 1  EX PE R I M E NTA L PROTOCOL 
A N D  EX PERIM E  TS I N  
Forty male G K  and W i  tar control rats aged 7 weeks were divided into 2 subgroups 
A l l  ani mal received normal rat chow and drinking water ad libItum One subgroup of 
GK and Control rats received normal drinking water for the ent ire duration of the 
experi ment whil t the other ubgroup received water containing 1 00 mM sucrose for 2 
month , 200 and 3 00 mM sucrose for 1 month and thereafter 400 mM sucrose 
Bodyweight, non-fast i ng blood glucose, food and water consumpt ion were measured 
periodical ly .  Ventricul ar myocyte experiments began after 6 and 8 months of dietary 
intervention Approval for this project was obtained from the Animal Ethics 
Committee, Col lege of Medicine & Health Sciences, United Arab Emirates 
University 
4. 1 . 2 V E N T R I C U L A R  M YOCYT E I SO LATION 
entricular myocytes were i solated from GK and control rats according to previously 
described techniques (Salem et at , 20 1 2) .  In brief, animals were euthanized using a 
gui l lotine and hearts were removed rapidly and mounted on a Langendorff perfusion 
system. Hearts were perfused at a 36-37 °C with cel l  i solation solution contain ing i n  
m molll 1 30 0 NaCl ,  5 4 KCI,  1 4 MgCh, 0.75 CaCh, 0.4 NaH2P04, 5.0 HEPES, 10 0 
glucose, 20 0 taurine and 1 0 0 creat i ne (pH 7 3) .  Perfusion flow rate was adjusted to 
allow for d ifferences i n  heart weight between ani mals. After heart contraction had 
stab i l ized, perfusion was cont inued for 4 min with Ca
2+ -free cel l i solation solution 
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containing 0 I mmol!l EGT to arrest the heart, and then for 6 min with cell i solation 
olut ion containing 0 05 mmolll Ca2+, 0 75 mg/ml type 1 col lagenase (Worthington 
Biochemical Corp, Lakewood, J, SA) and 0 075 mg/ml type XIV protease (Sigma, 
Tautk irchen, Germany) to produce i olated, quiescent, rod-shaped myocytes 
entncle t i s  ue was excI sed from the heart, minced and gent ly shaken in col lagenase­
contain ing i o lat ion olution upplemented with 1 % BSA Cel l s  were filtered from 
thi olution at 4 min interval s and resuspended in cel l i solat ion solution containing 
0 75 mmolll Ca2 Cel l s  were stored at 4 DC and used over a period of 1 - 1 0  hours, as 
cell were freshly i solated on daily basis 
4. 1 .3 M ES EA U RM ENT OF VENTRICU LA R MYOCYTE S H ORTEN ING 
Ventricular myocyte shortening was measured according to  previously described 
techniques (Salem et aI , 20 1 2) Cel l s  were superfused (3-5 ml/min)  with normal 
Tyrode containing the fol lowing in  mmolJl · 1 40 0  NaCl,  5 .0  KCI , 1 0 MgCh, 1 0 0 
gluco e, 5 0 HEPES,  1 8 CaCh (pH 7 4) .  Unloaded myocyte shortening was recorded 
using a VED- 1 1 4  video edge detection system (Crystal Biotech, Northborough, MA, 
USA)  Rest i ng cel l  lengt h, t ime to peak (TPK) shortening, t ime to half (THALF) 
relaxat ion and ampl itude of shortening (expressed as a % of rest ing cel l length )  were 
measured i n  field stimulated ( 1  Hz) myocytes maintained at 3 5-36 DC. Data were 
acquired and analyzed with Signal Averager software v 6 .37  (Cambridge Electronic 
Design, Cambridge, UK) 
4. 1 .4 M ES E A U R M E N T  OF I NTRACE LLU L E R  Ca2+ CONCENTRATION 
Myocytes were loaded with the fluorescent i ndicator fura-2 AM (F- 1 22 1 ,  Molecular 
Probes, Eugene, OR, USA) and myocyte shortening was measured according to 
previously described techniques (Howarth el aI. , 20 1 J ). In brief, 6.25 III of a 1 0 
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mmol I I tock olution of fura-2 M (dis  olved in DM 0) was added to 2 5  ml of 
cel l s  to give a final fura-2 concentration of 2 5 �mol l I Myocytes were shaken gently 
for 1 0  min at room temperature (24 °C) After loading, myocytes were centrifuged at 
500 rpm, wa hed with normal Tyrode solution to remove extracellular fura-2 and then 
left for 30 min to en ure complete hydrolysi s of the intracel lular ester. To measure 
int racel lu lar Ca2 concentration myocyte were alternately i l luminated by 340 nm and 
380 nm l ight using a monochromator (Cairn Research, Faversham, UK) which 
changed the excitation l ight every 2 mi l l i seconds The result ing fluorescence emitted 
at 5 ]  0 nm wa recorded by a photomult ipl ier tube and the ratio of the emitted 
fluore cence at the two excitation wavelengths (340/380 ratio) was calculated to 
provide an index of i ntracel lular Ca2� concentration. Resting fura-2 ratio, TPK Ca2 
transient, THALF decay of the Ca2� transient and the ampl itude of the Ca2
+ 
transient 
were measured i n  field st imulated (1 Hz) myocytes maintained at 3 5-36 0c . Data were 
acquired and analyzed with Signal Averager software v 6 37 (Cambridge Electronic 
De ign, Cambridge, UK) 
4. 1 . 5 M ES E A  U RM E N T  OF MYOFI LA ME NT SENSITIV ITY TO Ca2+ 
In some cel l s  shorten i ng and fura-2 ratio were recorded simultaneously Myofi l ament 
sensit ivity to Ca2� was assessed from phase-plane diagrams of fura-2 ratio vs. cel l  
l ength b y  measuring the gradient o f  the fura-2 - cel l length trajectory during late 
relaxat ion of t he twitch contraction as previously described ( Howarth et aI. , 20 1 2) .  
. C 2+ d The posit ion of t he trajectory refl ects t he relat ive myofilament response to a 
an 
hence, can be used as a measure of myofilament sensitivity to Ca
2+ (Spurgeon et al , 
1 992).  
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4. 1 .6 M EA RM E T O F  
T R A  PORT 
A RCOPLA M IC RETICU L C M  Cah 
arcoplasmic  reticulum ( R) Ca2 release was assessed using previously described 
technique ( Salem et al , 20 1 2 ) After estab l i shing steady state Ca2
+ 
transients in field 
st imulated ( 1  Hz) myocytes maintained at 3 5-36 °C and loaded with fura-2, 
stimulation wa pau ed for a period of 5 sec. Caffeine (20 mM) was then appl ied for 
1 0  sec using a solution switching device customized for rapid solution exchange (Levi 
el a/. , 1 996) Electrical t imulation was then resumed and the Ca2
+ 
transients were 
al lowed to recover to steady state Fractional release of SR Ca2">
-
was assessed by 
comparing the ampl itude of the electrical ly-evoked steady state Ca2� transients with 
that of the caffeine-evoked Ca2
+ 
transient Ca2
� 
refi l l i ng of SR was assessed by 
measuring the rate of recovery of electrical ly-evoked Cah transients fol lowing 
appl icat ion of caffeine 
�.2  E X P R ESSION O F  m RN A  
Expression of genes encoding a range o f  cardiac muscle proteins was assessed using 
modifications of previously described techniques (Howarth el aI. , 20 1 2, Howarth et 
al. , 20 1 1 ,  Salem et al , 20 1 2; Salem et aI. , 20 1 3) .  Samples of ventricle t issue were 
col l ected before removing the heart from the ani mal for cel l i so lat ion, and were frozen 
immediately i n  l iquid nitrogen and stored at -80 °C pending for further processi ng. 
I solat ion of  total RNA from t he t issue was performed using the SV Total RNA 
Isolation System ( Prom ega, Madison, USA) according to the manufacturer' s 
instruct ions The concentrat ion and purity of the RN A samples was determined by 
measuring the absorbance at 260 nm and the rat io of the absorbance at 260 nm and 
280 nm (ND- 1 000, NanoDrop). A two-step RT-PCR procedure was used to generate 
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cD Total R ( 500 ng) was converted mto cD 'A in a 25 III PCR reaction with 
1 0  x RT Buffer 2 0 Ill ,  25  x d TP Mix ( 1 00 mM)  0 8  Il l, 1 0  x RT Random Primers 
2 0 Ill, Mult I  cribeTM Re erse Transcriptase 1 .0 Ill, RNase inh ibitor 1 0 Jll, and 
uclease-free H20 (H igh Capacity cD A Reverse Transcription Kit (43 74966, 
ppl i ed Biosystems, SA) Reverse transcript ion was carried out using the fol lowing 
parameter values 25 °C for 1 0  min, 3 7 °C for 1 20 min, and 85 °c for 5 min on the 
Verit i  thermal cycler (Appl ied Biosystems, USA) Gene Expression Assays were 
performed using custom Taqman Low Density Arrays (Format 32, 4346799, Applied 
Biosy terns, USA) .  The Taq Man assays are pre-loaded in each react ion wel l of the 
array In tr ipl icate for each RNA sample. Rat hypoxanthine guamne 
phosphoribosyltransferase (Hprt l )  was used as the endogenous control (Howarth et 
aI. , 20 1 2 ; Howart h  et aI. , 20 1 1 ). 1 00 ng of cDNA ( RNA-equivalent ) was loaded 
together with 2 x TaqMan Gene Expression Master Mix  (No AmpErase UNG, 
Appl ied B iosystems, USA)  for a total of 1 00 ilL per port . Real-time RT-PCR was 
performed i n  a 7900HT Fast ABI Prism 7900HT Sequence Detection System 
( Appl ied Biosystems, USA)  The PCR thermal cyc l ing parameters were run i n  
standard mode as  fol lows: 50 °C for 2 min ,  94. 5  ° c  for 1 0  min, fol lowed by 4 0  cycles 
of 97 °C for 30 sec and 59 7 for 1 min .  Results were in i t ia l ly analyzed using ABI 
Pri sm 7900HT SDS,  v2 .4 .  Al l  remain ing calculations and statist ical analysis were 
performed by t he S DS RQ Manager 1 . 1 . 4 software using the 2-��Ct method with a 
relat ive quant ificat ion RQminIRQmax confidence set at 95 %. 
4.3 STA T I STICS 
Results were expressed as the mean ± S .E M.  of 'n '  observations. Stat istical 
compar isons were performed using ANOV A and Bonferroni post-hoc test (SPSS v. 
20), p < 0 05 was considered to i ndicate a significant difference 
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5. VE T R I  LA R MYOCYTES SHORTEN I N G A N D  Ca2+ TRA N PORT 
1 GOTO- K A K IZA K I  RAT FED A UCROSE-E r uC H E D  D I ET 
5. 1 T TRODUCTIO 
Diabetes Mel l itu ( D M )  i currently the fastest growing disease in the world 
Cardiova cular compl ications are considered a a major cause of morbidity and 
mortal ity in  d iabet ic pat ients The aim of th is  study was to investigate the effect of 
T2DM on the heart , forty male GK and Wistar control rats aged 7 weeks were divided 
into 2 ubgroups. A l l  ani mal s received normal rat chow and drinking water ad 
lihllum One subgroup of GK and Control rat s  received normal drink ing water for the 
ent ire durat ion of the experiment whi l st the other subgroup received water containing 
1 00 m 11 ucrose for 2 months, 200 and 300 mM sucrose for 1 month and thereafter 
400 m M  sucrose. Ventricular myocyte experiments began after 6 months of dietary 
intervention 
5.2 M ETHODS 
The general characterist ics of  the  GK and Control rats were measured periodical ly 
(bodyweight, non-fast ing b lood glucose, food and water consumption) After 6 &/or 8 
months of d ietary i ntervent ion, left ventricular myocytes were isolated from GK and 
Control rats according to previously described techniques (page. 45)  Shorten ing and 
intracel l ul ar Ca2
+ 
were measured in ventricular myocytes with video edge detection 
and fl uorescence photometry, respect ively as described before (page. 46). Al so, 
2+ I " I C 2
+ 
rt ere myofilament sensit ivity to Ca and sarcop asmlc ret lcu urn a transpo w 
measured according to previously described techniques (page 47 & 48) 
52 
5.3 R E  LT 
5.3. 1 6 M O  T H  DI ETA RY I T E R VE TION 
5.3. 1 . 1  General Characteristics of Control  and Goto-Kakizaki Rats 
Experi ments were performed after the ani mal s had been receiving a modified diet 
for a period of 6 month The general characteristics of the animals are shown i n  
Table  5 1 Bodyweight, heart weight and heart weight to  bodyweight ratio were 
not ign ificantly ( p>O 05)  different in the 4 groups of animals. Although non-
fast i ng b lood glucose was only modest ly i ncreased in GK compared to Control 
rats, feed ing GK rat with Sucrose resulted in a significant (p<0.05 ) 3-fold 
increase in  blood glucose compared to Control rats .  Blood glucose was also 
significant ly (p<0.05)  elevated in  GKJSucrose compared to ControVSucrose rats .  
Table  1 - General characterist ics of Control and GK animals 
Control ( 1 )  ControVSucrose GK (3)  GKJSucrose 
(2)  (4) 
Bodyweight 3 89.67±22 40 362 . 33± 1 7 .9 1 425 .00±7.09 444 . 33± 1 8 37  
(g) 
Heart weight 1 . 3 0±0.06 I 27±0.03 1 40±0.00 1 47±0 07 
(g) 
Heart weight 3 . 3 5±0. 1 2  3 . 50±0. 1 O  3 . 30±0.05 3 . 30±0.02 
Bodyweight 
(mg/g) 
Blood glucose 85 67±3 . 7 1  1 06.67± 1 5 . 8 1 1 57 67± 1 2 . 8 1  223 00±30 04 
(mg/dl )  
Data are mean±SEM. Number of  ammals I n  each group - 3 .  Slgmficance values refer 
to numbers i n  parenthesis Blood glucose 1 -4 * * ,  2-4 *  
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5.3. 1 . 2 Ventricu lar  Myocyte horten ing 
Figure 5 1 shows rest ing cel l  length (a) ,  TPK (b), THALF relaxation of shortening (c) 
and ampl i tude of hortening (d) Rest ing cel l length in  myocytes from GK 
( 1 46.84±4 46 11m, n= 27 cel l s) was significantly (p<0.05) longer than in myocytes 
from Control/ ucro e ( 1 27 53:1:4 84 11m, n=20 cel ls)  rats (Figure 5 l a) . TPK 
shorteni ng wa not ignificantly ( p>O 05)  altered in myocytes from GK compared to 
Control or in GKJ ucrose and Control/Sucrose compared to GK and Control rats, 
respectively (F igure 5 I b )  THALF shorteni ng was not significantly (p>0.05) altered 
in myocytes from GK compared to Control or in GKfSucrose and Control/Sucrose 
compared to GK and Control rats, respect ively (Figure 5 . l c) Ampl itude of shortening 
was not sign ificant ly (p>O 05)  altered in myocytes from GK compared to Control or 
in GKfSucrose and Control/Sucrose compared to GK and Control rats, respectively 
(Figure S I d) .  
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Figure 5 . 1 - Ventricular myocyte shorten ing i n  GK and Control rats fed sucrose-
enriched diets. Rest i ng cel l  length (a), t ime to peak (TPK) shortening (b), time to half 
(THALF) relaxat ion of shorten ing (c) and ampl i tude of shorteni ng, expressed as a 
percentage of rest i ng cel l  length ( RCL) (d) III myocytes from Control, 
ControVSucrose, GK and GKiSucrose rats. Data are mean ± SEM, n=20-3 1 cel ls  
Horizontal l ines above bars represent significant differences * p<O.05 
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5.3. 1 .3 Ven t ricular  M yocyte I n tracel lu lar  Ca2+ 
Figure 5 2  shows rest i ng fura-2 ratio (a), TPK Ca2 transient (b), THALF decay of the 
Ca2 transient (c) and amplitude of the Cah transient (d) Resting fura-2 ratio (R ) 
wa signifi cantly ( p<O 05)  reduced in myocytes from GKJSucrose (0 64±0 02 RU 
n=24 cel ls )  compared to myocyte from Control (0  72±0 02 RU, n=29 cel ls) rats 
(F igure 5 2a) TPK Ca2 tran ient was significantly ( p<O 05)  prolonged in myocytes 
from GKJSucrose (68 68±3 .0 1 ms, n=22) compared to GK Control ( 55  82±2 47 ms, 
n=25 )  and in myocytes from GKfSucrose (68 68±3 0 1  ms, n=22) compared to 
m ocytes from Control/Sucrose ( 5 5 9 1 ±2.98 ms, n=2 1 cel l s )  rats (Figure 5 2b)  
THALF decay of the Ca2 transient was not significant ly (p>O 05)  altered in myocytes 
from GK compared to Control or in GKfSucrose and Control/Sucrose compared to 
GK and Control rats, respectively (Figure 5 . 2c). Ampl itude of the Ca2+ transient was 
larger i n  myocytes from GKfSucrose (0 .25±0.03 RU, n=24 cel l s) compared to 
myocytes from Control (0. 1 6±0 0 1  RU, n=29 cel l s) rats (Figure 5 . 2d). 
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Figure 5 2  - Ventricu lar myocyte intracel lu lar Ca2
+ in  GK and Control rats fed 
sucrose-enriched diets.  Rest ing fura-2 ratio (a), t ime to peak (TPK) Ca2 transient (b), 
time to half (THALF) decay of the Ca2
+ transient (c) and amplitude of the Ca2+ 
transient (d) i n  myocytes from Control, Control/Sucrose, GK and GK/Sucrose rats .  
Data are mean ± SEM, n=2 1 -29 cel l s. Horizontal l ines above bars represent 
significant differences * p<O.05 
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5.3. 1 .4 Myofilament ensit ivity to Ca2+ 
Figure 5 3  how myofilament sensit iv ity to Ca2
+
. Figure 5 3a i s  a typical record of 
hortening and Ca2+ transient in a control myocyte. Figure 5 3b is a phase-plane 
diagram of fura-2 ratio  vs cel l length . The gradient of the fura-2 - cel l  length 
trajectory during late (500-800 ms) relaxation of the twitch contraction was not 
ign ificantly (p >0.05 )  altered in myocytes from GK compared to Control or i n  
GKiSucro e and ControVSucro e compared to  GK and Control rats, respectively 
(Figure 5 3c)  
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Figure 5 . 3  - Myofilament sensit ivity to Ca2+ in GK and Control rats fed sucrose-
enriched diets .  F igure 6 .3a  shows a typical record of shortening and Ca2-t transient in a 
control myocyte. Figure 6 . 3b  is a phase-plane diagram of fura-2 ratio vs. cel l length 
(arrow indicates where the gradient was measured) . The gradient of the fura-2 - cel l 
length trajectory during late (500-800 ms) relaxation of the twitch contraction i s  
shown i n  Figure 6 3c .  Data are mean ± SEM, n= 1 5-23 cel ls  
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5.3.2 8 M O  T H  D I ET RY I T ERVE TIO 
5.3.2. 1 General Characterist ics of Con t rol and Goto-Kakiza ki Rats 
Change In bodyweight are hown in Figure 6 I a At 8 months of dietary intervention 
the final gain in bodyweight in decreasi ng order was. GKiSucrose > GK > 
Control/ ucro e > Control rats The bodyweights of GK (442 38±6.08 g, n= 1 6) and 
GKJ ucro e (445 08±8 98 g, n= 1 2 ) were significantly (p<0.05) higher than 
Control/ ucrose (42 1 28± 1 3 . 36, n= 1 4) and Control (383 3 1 ± 1 4 . 33  g, n= 1 3 )  rats 
Changes in non-fa t ing blood glucose are shown in Figure 6 . 1 b. At 8 months of 
dietary i ntervent ion the fi nal non-fast ing blood glucose in decreasi ng order was 
GKJ ucro e > GK > Control/Sucrose > Control The non-fast ing blood glucose in  
GK/Sucrose (254 , 25±20, 5 1 ,  n= 1 2 ) was significantly (p<0.05)  higher than GK 
( 1 43 06±6 67 mgldl ,  n= 1 6), Control/Sucrose ( 1 l 0. 93± L 76 mgldl, n= 1 4) and Control 
(95 77±3 .77 mgldl, n= 1 3 ) rats on-fast ing b lood glucose was also significantly 
( p<O 05 )  h igher in GK compared to Control rats Changes in food consumption are 
hown in Figure 6 . 1 c  At 8 months of dietary intervention the final food consumption 
in decrea ing order was. GK > Control > GKfSucrose > Control/Sucrose rats At 8 
months of d ietary i ntervention food consumption of GK (25 ,  1 4±0.8 glrat/day4, n= 1 6) 
was significantly (p<0 05 )  h igher than Control ( 1 7.09±0.3 1 glrat/day, n= 1 3 ), 
GKfSucrose ( l 0. 83± 1 . 3 7  glrat/day, n= 1 2) or Control/Sucrose (6. 48±0.34 glrat/day, 
n= 1 4) rats Food consumption of Control was also significantly (p<0.05)  h igher than 
in GKfSucrose and Control/Sucrose rats. Changes in l iquid consumption are shown 
i n  figure 6. 1 d  At 8 months of dietary intervent ion l iquid consumption in decreasing 
order was GKfSucrose > Control/Sucrose > GK > Control Liquid consumption in 
GKfSucrose ( 1 64.65±5 76 m llrat/day, n= 1 2) was significantly (p<0.05) h igher than 
Control/Sucrose (80 . 24± L I S  ml/rat/day, n= 1 4), GK (50 ,06±0, 97 mllrat/day, n= 1 6) 
60 
and Control ( 33  85±0 25 mllrat/day, n= 1 3 )  rat Liquid consumption of 
Control! ucro e was also igni ficantly (p<O 05)  higher than GK and Control rats 
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Figures 5 . 4  - General characteristics of GK and Control rats fed sucrose-enriched 
diets Bodyweight (a), non-fast ing blood glucose (b), food consumption (c) and l iquid 
consumption (d) in Control, Control/Sucrose, GK and GKlSucrose rats. Data are 
mean ± SEM, n= 1 2- 1 6  rats 
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5.3.2.2 Ven tricular M yocyte Sh orten ing 
Figure 6 2  shows rest ing cel l length (a), TPK shortening (b), THALF relaxation of 
hortening (c) and ampl itude of shortening (d) Resting cel l length in GK 
( 1 5 5 63±4.9 1 � m, n= 39 cel ls)  was significantly (p<O 05) longer than in  Control 
( 1 39 48±2 98 �m, n=47 cell ) myocytes Rest ing cell length in GKfSucrose 
( 1 49.49±3 7 1  � m, n-46 cel l s) and Control/Sucrose ( 1 3 5 6 1 ±3 5 1  �m, n=36 cel ls)  
were not significantly (p>O 05)  different from RCL in  GK and Control myocytes, 
respect ively TPK shortening in GK ( l 36 . 1 5±5 .36  ms, n=39 cells) was significantly 
( p<O OS)  prolonged compared to Control ( 1 1 9 .77±2 93 ms, n=47 cel l s) THALF 
relaxation of shortening was not significantly (p>O 05) altered in  GK compared to 
Control myocytes or in GKfSucro e or Control/Sucrose compared to GK and Control 
myocytes, respect ively. Ampl itude of shortening was signi ficant ly (p<0.05) reduced 
i n  Control/Sucrose ( S  26±0 3 8  %, n=36 cel l s) compared to Control (6 52±0 3 1  %, 
n=47 cel ls)  Ampl itude of shorteni ng was also modest ly reduced i n  GKfSucrose 
(S 94±0 28 0'0, n=46 cel l s) compared to GK (7 l S±O 40 %, n=39 cel l s) however, the 
difference did not reach statist ical sign ificance (p>O.OS) .  
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Figure 5 5 - Ventricu lar myocyte shortening in  GK and Control rats fed sucrose-
enri ched diets Rest i ng cel l  length (a), t ime to peak (TPK) shortening (b), time to half  
(THALF) relaxation of shorten i ng (c)  and ampli tude of shortening, expressed as  a 
percentage of rest i ng cel l  l ength ( RCL) (d) In  myocytes from Control, 
ControVSucrose, GK and GKiSucrose rats. Data are mean ± SEM, n=36-47 cel l s .  
Horizontal l i nes above bars represent significant differences. * p<O.05 
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5.3. 2.3 Vent ricular  Myocyte In t racellu lar Ca2+ 
Figure 6 3  shows re t i ng fura-2 ratio (a), TPK Ca2+  transient (b), THALF decay of the 
a2 t tran ient (c)  and ampl itude of the Ca2+ transient Cd) Rest ing fura-2 ratio (RU) 
Vvas not significantly (p>O 05 )  altered in GK compared to Control myocytes or in 
GKI ucro e or ontrol/ ucro e compared to GK and Control myocytes, respect ively. 
TPK Ca2 transient was significantly (p<0.05)  prolonged in GK (66. 1 4± 1  99 ms, 
n=42) compared to Control ( 5 5  82±2 47 ms, n=25) .  TPK Ca2 transient was not 
sign ificantly (p>0 .05)  altered in GKlSucrose and Control/Sucrose compared to GK 
and Control myocytes, respect ively THALF decay of the Ca2
+ transient was not 
ign ificantl ( p>0.05) altered in GK compared to Control myocytes or in GKJSucrose 
or Control/Sucrose compared to GK and Control myocytes, respectively. Ampl itude 
of the Ca2
+ transient was sign ificantly (p<O 05) i ncreased in Control/Sucrose 
(0 3 6±0.02 RU, n=32) compared to Control (0 25±0.02 RU, n=25) and significant ly 
(p<O 05) decreased in  GKJSucrose (0 24±0.02 RU, n=34) compared to GK (0.3 1 ±0 02 
RU, n=42) myocytes. 
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Figure 5 . 6  - Ventricular myocyte i ntracel lu lar Ca2+ i n  GK and Control rats fed 
sucrose-enriched diets  Rest ing fura-2 ratio (a), time to peak (TPK) Ca2T transient (b), 
time to half (THALF) decay of the Ca2+ transient (c) and ampl itude of the Ca2
+ 
transient (d)  i n  rnyocytes from Control, ControVSucrose, GK and GK/Sucrose rats 
Data are mean ± SEM, n=25-42 cel l s  Horizontal l i nes above bars represent 
significant differences. * p<O.05 
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5.3.2.4 Myofila ment  en i t iv i ty to Ca2+ 
Typical record of honen ing and Ca2 t ransient in an electrical ly st imulated ( 1  Hz) 
myocyte from a control rat is shown in figure 6 4 Figure 6 Sa shows a typical phase-
plane d iagram of fura-2 rat io vs cel l  length The gradient of the fura-2 - cel l length 
trajectory duri ng late (500-800 ms) relaxat ion of the twitch contraction was 
signi ficant ly (p<O 05 )  i ncreased in GK compared to control myocytes. However, the 
gradient was reduced (p>O 05)  in GK/Sucrose compared to GK (Figure 6. Sb) 
5 !Jm 
0.5 RU --r�----------________ __ 
o 0.1 0.2 0.3 0.4 0.5 0.6 0.7 .8 
Time (ms) 
Figure 5 7 - Typical record of shorten ing and Ca2+ transient in myocytes from a 
control cel l .  
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5.3.2.5 arcopla m ic Reticulu m  Ca2+ Tran port 
Figure 6.6 shows a typ ical record of electrica l ly-evoked and caffeine-evoked Ca2> 
transIents in  a ontrol myocyte Area under the curve of the caffeine-evoked Ca2t-
tran ient (F igure 6 7a), fractional release of SR Ca2 (amplitude of the electrical ly-
evoked / caffeine-evoked a2 transients) (Figure 6 7b)  and recovery of the Ca2 
tran ient after appl ication of caffeine and resumption of electrical stimulation (Figure 
6 7c) were not significantly (p>O 05)  altered in GK compared to Control or i n  
GKJ ucrose and Control/Sucrose compared to  GK and Control myocytes, 
respectively 
0 1  RU I 
Caffeine 
application 
Electrical 
st imulation 
1 0  sec 
E lectrical 
stimulation 
F igure 5 9 _ Typical record of electrical ly-evoked and caffeine-evoked Ca
2T transients 
in a ventricular myocyte from a Control rat . 
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+ 
transient (a), fractional release of SR Ca2
+ 
(ampl itude of the electrica l ly-evoked / 
caffeine-evoked Ca2 transients) (b) and recovery of Ca2
+ 
transients fol lowing 
appl icat ion of caffeine and resumption of electrical st imulation (c). Data are mean ± 
SEM, n=3 1 -49 cel l s  
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5.4 D J  C 10 
There are a wide variety of r 'sk c: t c: d' b I lac ors lor la  etes and these include obesIty, 
edentary l ifestyle unhealth·y e t ' h b ' c: '1 h ' ' " , a mg a ItS, lam l Y I StOry, genetics, increasIng age, 
high blood pre sure and h igh cholesterol In the current study the effects of diet ,  and 
in particular a ucrose-enriched diet, on dietary habits, blood glucose and ventricular 
myocyte horten ing and Ca2 transport have been invest igated in  the GK type 2 
diabet ic  rat The major findings of the study were ' i )  bodyweight i n  decreasing order 
was GKJ ucrose > GK > ControVSucrose > Control rats; i i )  non-fasting blood 
glucose i n  decreasing order was GKJSucrose > GK > ControVSucrose > Control, i i i )  
food consumption i n  decreasing order was GK > Control > GKJSucrose > 
ControVSucrose rats, iv)  l iquid consumption i n  decreasing order was: GKJSucrose > 
ControVSucrose > GK > Control , v) TPK shortening was prolonged in GK compared 
to Control myocytes and ampl itude of shortening was reduced i n  ControVSucrose and 
mode t Jy reduced i n  GKJSucrose compared to Control and GK myocytes, 
respect ively; v i )  TPK Ca2� transient was prolonged in GK compared to Control 
myocytes and ampl itude of the Ca2+ transient was increased i n  ControVSucrose and 
decreased in GKJSucrose compared to Control and GK myocytes, respectively; vi i )  
myofilament sensitivity to Cah was altered i n  GK compared to Control myocytes and 
in GKJSucrose compared to GK myocytes. 
After 8 month of dietary intervent ion the fi nal gain in  body mass of the groups i n  
decreasing order, was: GKJSucrose > GK > ControVSucrose > Control rats Some 
previous studies where normal rat chow was provided ad lIbitum have demonstrated 
t hat GK rats tended to gain less weight than Controls (Howarth et aI. , 2008; Howarth, 
Shafiullah & Qureshi,  2007) .  Another study demonstrated that sucrose-fed rats gained 
less weight compared to control s whi l st sucrose-fed GK rats gained more weight than 
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GK controls (Koyama el ill , 1 998)  Differences in  experimental methodology and 
perhap smal l  differences in genet ic profiles between batches of animals may part ly 
explain the d ifferences in  weight gain. 
Non-fast ing blood glucose was highest In  GKlSucrose rats fol lowed by GK, 
Control/Sucro e and Control rats According to the American Diabetes Associat ion 
( 'American Diabetes A ociation - The American Diabetes Association' 20 1 4), 
fast i ng p lasma glucose levels  between < 1 00 mg/dl are considered normal ,  levels 2: 
1 00 mgldl and < 1 26 mg/dJ are considered pre-diabetic and values 2: 1 26 mgldl are 
considered diabetic . At the beginning of the study the GK rats had a non-fast ing blood 
gluco e alue of 1 42 mg/dl compared to 1 1 5 mgldl in Controls. By the end of the 
study, the blood glucose had risen to 254 mg/dl in GKlSucrose rats compared to 1 43 
mgldl i n  GK rats and 96 mgldl in  Control s. The sucrose-enriched diet worsened the 
diabet ic state in GK rats. Previous studies over periods up to 1 5  months of age have 
a lso demonstrated a progressive rise of blood glucose in GK compared to Control rats 
(Howarth et al , 2008) Interestingly, in  a shorter 1 2  week study Koyama et al ( 1 998) 
reported that blood glucose was increased in GK rats compared to Controls was 
modest ly increased in sucrose-fed compared to control rats and was reduced in  
sucro e-fed GK rats compared to GK rats. Associated with these changes in blood 
glucose were elevated fast i ng p lasma i nsul i n  in sucrose-fed Control and sucrose-fed 
GK rats compared to Control and GK rats, respect ively (Koyama et aI. , 1 998) 
Unpub l ished ELI S A  data from our lab has also shown an increase i n  non-fasting 
plasma insu l i n  i n  GKiSucrose compared to GK and in Control/Sucrose compared to 
Control rats 
GK and Control rats ate more food and drank less l iquid than GKiSucrose and 
Control/Sucrose rat s. Based on an assumpt ion that animals eat to meet metabol ic  
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demand, the GKJ ucrose rats and the Controll ucrose rats would have obtained 
calorie from drink ing the ucro e-enriched water and therefore, it is not surprising 
that they would not need to consume as much sol id  diet to maintain metabol ic demand 
(Torregros a el al , 20 1 2 ) Previous tudies in our laboratory have shown that GK rats 
fed a low fat (h igh carbohydrate) diet ate more than GK rats fed a high fat ( low 
carbohydrate) diet (Howarth et al , 20 1 1 ) . The energy content per gram of the high fat 
diet was higher than the low fat diet and therefore rats did not need to eat as much to 
sat i sfy their metabol ic needs A number of studies have demonstrated that given a 
choice, rats wi l l  chose to drink sucrose-enriched water compared to water alone 
(Gal ic  & Persinger, 2002; Hsiao & Chen, 1 995;  Torregrossa et al. ,  20 1 2) . 
After 6 months of dietary i ntervention, ventricular myocyte shortening was wel l  
preserved in  GKJSucrose rats compared to G K  and Control rats, whi le after 8 months 
myocyte lengt h  was significantly increased in GK compared to Control myocytes. 
TPK shorteni ng was prolonged in GK compared to Control myocytes The amplitude 
of shortening was sign ificantly reduced i n  myocytes from ControlfSucrose compared 
to Control rats, however it i ncreased GK compared to Control myocytes. Previous 
studies have demonstrated an i ncreased ampl itude of shorteni ng in myocytes from GK 
rats compared to Controls and have variously showed unaltered myocyte longitudinal 
length, reduced shortening, s lower time to peak twitch and prolonged relaxation i n  
normal healthy rats receiv ing sucrose-enriched diets ( Davidoff e t  at. ,  2004, Dutta et 
aI. , 200 1 , Howarth & Qureshi, 2008; Howarth, 2004). 
At 6 months of  dietary intervention, TPK Ca2T transient was prolonged in  myocytes 
from GKJSucrose compared to GK and i n  GKJSucrose compared to ControlfSucrose 
rats Prev ious experiments in normal healthy rats fed sucrose-enriched diet have 
demonst rated prolonged decay of the Ca2� transient suggesti ng prolonged cytoplasmic  
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Cal clearing ( Dutta el al , 200 1 ) Interest ingly, the ampl itude of the Cal. transient 
wa larger in myocytes from GKJ ucro e compared to Control rats There was a 
tendency for increasing ampl itude of the Cal transient in myocytes in the order 
Control- ontrol/ ucrose-GK-GKJ ucrose Previous experi ments have demonstrated 
reduced ampl itude of the Cal transient in myocyte from GK compared to Control 
rat and increased ampl itude of the Ca2 transient in myocytes from rats receiving a 
sucrose-enriched diet (Howarth & Qureshi, 2008; Howarth, 2004). Later at 8 months 
of d ietary intervention, TPK Ca2 transient was al so prolonged in GK compared to 
Control myocytes uggest ing that the prolongation of shortening might be attributed 
to the prolongat ion of the Ca2 transient . Slower time course for entry of L-type Cal 
current, the primary trigger for SR Cal+ release, and/or release of Ca2
+ from the SR 
m ight under l ie  t he prolonged TPK of the Cal transient . The ampl itude of the Ca2 
transient was sign ificantly increased in  myocytes from Control/Sucrose compared to 
Control rat, however it was significantly reduced in myocytes from GKiSucrose 
compared to GK rats. 
Myofi lament sensitivity to Cah was assessed from phase-plane diagrams of fura-2 
ratio versus cel l  l ength by measuring the gradient of the fura-2-cel l  length trajectory 
during late relaxat ion of the twitch contraction. The position of the trajectory during 
the relaxat ion p hase reflects the relat ive myofi lament response to Ca2+ and, hence, can 
be used as a measure of myofilament sensit ivity to Ca2+ (Spurgeon et aI , 1 992). 
Myofilament sensit ivity was unaltered in myocytes from GKiSucrose rats compared 
to GK, Control/Sucrose and Control rats at 6 months' t imel ine. After 8 months of 
dietary intervention, the gradient of the trajectory during the relaxation phase of the 
twitch contraction was significantly greater for GK myocytes compared to controls 
suggest ing that myofilament sensit ivity to Ca2+ is increased in GK myocytes 
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compared to controls Previous studies i n  STZ-induced diabetic rats, which i s  a 
widely u ed experimental model of type 1 DM., have also demonstrated an increase in  
myofi lament ensit ivity to  Ca2 ( Howarth, 200 1 ;  Khandoudi el  aI. , 1 993 ; Woodall el 
£II. . 2004 ) Meanwhi le, the grad Ient of the trajectory during the relaxation phase of the 
twitch contract ion was ign ificant ly reduced in GK/Sucrose myocytes compared to 
GK, uggest ing that myofi laments sensit ivity to Ca2 was decreased in  GK/Sucrose 
myocytes 
To further i nvest igate the mechanisms of Ca2+ transport, various measures of SR Ca2
+ 
trarl port i ncluding areas under the caffeine-evoked Ca2 transient fractional relea e , 
of Ca2t (ampl itude of the electrical ly-evoked / caffeine-evoked Ca2+ transients) and 
recovery of the Ca2 transients fol lowing appl ication of caffeine and during 
resumption of electrical st imulation, were invest igated . None of these measures were 
found to be sign ificantly altered in  GK rats compared to Controls or in 
ControVSucrose and GKJSucrose compared to Control and GK rats, respectively 
C learly di sturbances in S R  Cal-<- transport do not appear to underl ie the increased and 
decreased ampl i tudes of Ca2+ t ransient in myocytes from ControVSucrose and 
GKiSucrose compared to Control and GK rats, respectively. 
Prolonged t ime course of shortening in GK compared to Control myocytes might be 
attributed to a s lowed rate of Ca2+ influx via L-type Ca2' channels and/or release of 
SR Ca2 , which in turn would be cons istent with the observed prolongat ion of the 
Ca2+ transient .  Reduced ampl itude of shorten ing in  GK compared to Control 
rnyocytes m ight be attributed to a reduction in L-type Ca2+ current and/or a reduction 
in release of SR Ca2 , which in tum would be consi stent with the observed reduction 
in  ampl itude of t he Ca2� traIlsient. Alterations i n  myofi lament Cah sensitivity might 
partly under l ie  the reduced ampl itude of shortening and increased ampl itude of the 
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Cal tran ient I n  Control/Sucrose compared to Control myocytes (Howarth & 
Qureshi ,  2008)  
I n  conclu ion ,  ventncular myocyte shortening was wel l preserved despite some 
alteration in Ca2 transport in GK rats receiving a sucrose-enriched diet for 6 months 
Whi le  fi nd ings after 8 months of dietary intervention suggest that the longer the 
duration of exposure to risk factors, the worse the effects on the heart as wel l as the 
whole body 
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Chapter 6 
E X PRESS I ON O F  m RN A  I N  V ENTRICULAR 
T I SS U E  I N  GOTO-KA K I ZA KI RATS FED A 
S U C ROSE- E N R I C E D  D I ET 
(8  M ON T H S  D I ETA RY I NTERV E N RTION) 
RESULTS AND DISCUSSION 
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6. EX P R E  10 O F  m R  A I VE T R I C U L A R  TI  SU E I N  GOTO­
K A K IZA K I  RAT F E D  A UCROSE-E RIC H E D  D I ET ( 8 MO THS 
D I ETA R Y  T NT E R V E N RT ION)  
6. 1 I N TRO DUCTIO 
Diabete Mel l itus (DM) i s  current ly the fastest growmg di sease in the world 
Cardiovascular compl ications are considered as a major cause of morbidity and 
mortal ity in diabet ic pat ients. The aim of th is  study was to investigate the effect of 
T2DM on the heart, forty male GK and Wistar control rats aged 7 weeks were divided 
i nto 2 subgroups A l l  animals received normal rat chow and drink ing water ad 
I7blllllJ1 One subgroup of GK and Control rats received normal drink ing water for the 
ent i re durat ion of the experi ment whi l st the other subgroup received water containing 
1 00 mM sucrose for 2 months, 200 and 300 mM sucrose for 1 month and thereafter 
400 mM sucrose. Expression of mRNA experiments were performed in ventricular 
t issue after 8 months of d ietary intervention. 
6.2 M ET H O DS 
Expression of genes encod ing a range of cardiac muscle proteins was assessed with 
RT -PCR according to previously described techniques (page 48). 
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6.3 R E  U LT 
The target gene are Ii ted in Table 2 
Table 2 - Target genes and al ternat ive of genes names selected for real-t ime RT - peR 
I 
analyse 
Cardiac m u scle proteins and associated regu latory proteins 
Gene Al ternative name 
r--Myh6 Myosin, heavy polypept ide 6, cardiac muscle, alpha 
Myh7 Myo in, heavy polypeptide 7, cardiac muscle, beta r--
Mybpc3 Myosi n binding protei n C 
M I l Myosi n, l ight chai n I 
r---
Myosin, l ight chai n 3 Myl3 
Mylpf Myosin l ight chain, phosphorylatable, fast 
etc ] Act in ,  alpha, cardiac muscle 1 
Tnni3 Troponin I type 3 ,  cardiac 
Tnnt2 Troponin T2, cardiac 
Tpm l Tropomyosin I ,  alpha 
Tpm2 Tropomyosin 2, beta 
Tpm4 Tropomyosin 4 
Dbi Tit in protei n homolog 
I n tercellu l a r  p roteins 
Gja l  Gap junction protein, alpha- l 
Gja4 Gap junction protein, alpha 4 
Gja5 Gap junction protein, alpha 5 
Gja7 Gap junct ion protein, alpha 7 
Cav l Caveol in  1 
Cav3 Caveol in  3 
I n t racel lu lar  CaL+ transport and Ca.L+ regu lation 
ATP2a l ATPase, Cal
+ transporting, cardiac muscle, fast twitch 1 
Atp2a2 ATPase , Cal
+ 
t ransporting, cardiac muscle, slow twitch 2 
Ryr2 Ryanodine receptor 2, cardiac 
Casq2 Cal sequestrin 2 
PIn Phospho lamb an 
Calm2 Calmodul in  2 
Cel l m e m b ra n e  t ra nspo rt 
Atp l a l  ATPase, alpha 1 polypept ide 
Atp l a2 ATPase, alpha 2 polypeptide 
Atp l a3 ATPase, alpha 3 polypeptide 
Atp 1 b l  ATPase, beta 1 polypeptide 
S lc8a l Solute carrier fami ly 8 
Slc9a l Solute carrier fami ly 9, member 1 
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Calci u m  chan nel 
Cacna J c  Calcium channel, alpha 1 C subunit 
Cacna l g  Calcium channel, alpha 1 G subunit >---
Cacna l h Calcium channel, alpha I H  subunit 
acna2d l Calcium channel, aJpha2/delta subunit 1 f--
Cacna2d2 Calcium channel, alpha 2/delta subunit 2 
Cacnb 1 Calcium channel, beta 1 subunit r--
acnb2 Calcium channel, beta 2 ubunit I---
Cacnb3 Calcium channel, beta 3 subunit 
Cacnb4 Calcium channel, beta 4 subunit r--
od i u m  channel 
i--
cn5a Sodium channel,  type 5 ,  alpha 
Scn l b  Sodium channel, type I ,  beta 
Scn3b Sodium channel, type 3 ,  beta 
Potass ium channel 
Hcn2 Hyperpolarizat ion-act ivated cycl ic nucleotide-gated K� channel 2 
Hcn4 Hyperpolarizat ion-activated cycl ic nucleotide-gated K
+ 
channel 4 
Kcna2 Potassium channel, shaker-related subfami ly, member 2 
Kcna3 Potassium channel, shaker-related subfami ly, member 3 
Kcna4 Potassium channel, shaker-related subfami ly, member 4 
Kcna5 Potassium channel, shaker-related subfami ly, member 5 
Kcnj 2  Potassium channel, subfamily J ,  member 2 
Kcnj 3  Potassium channel, subfamily J ,  member 3 
Kcnj 5  Potassium channel, subfami ly  J ,  member 5 ( I K, Ach) 
Kcnj 8  Potassium channel, subfami ly  J ,  member 8 
Kcnj 1 1  Potassium channel 
Kcnj 1 2  Potassium channel, subfami ly J ,  member 1 2  
Kchip2 A-type potassium channel, protein 2 
Kcnab I Potassium voltage-gated channel shaker related subfamily beta, member 1 
Kcnb l Potassium voltage-gated channel, Shab-related subfami ly, member 1 
Kcnd I Potassium voltage-gated channel, Shal-related fami ly, member 1 
Kcnd2 Potassium voltage-gated channel, Shal-related fami ly, member 2 
Kcnd3 Potassium voltage-gated channel, Shal-related fami ly, member 3 
Kcne l Potassium voltage-gated channel, I sk-related subfami ly, member 1 
Kcne3 Potassium voltage-gated channel , I sk-related subfami ly, member 3 
Kcnq I Potassium voltage-gated channel, KQT-l ike subfami ly, member I 
Kcng2 Potassium voltage-gated channel, subfami ly G, member 2 
Kcnh2 Potassium voltage-gated channel, subfami ly  II, member 2 
Kcnk3 Potassium channel, subfamily K, member 3 
Kcnn2 Potassium intermediate/smal l conductance calcium-activated channel , 
subfami ly N, member 2 
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Level of spec ific mR reflecti ng the expres ion of genes encoding a variety of 
cardiac muscle, i ntercel lu lar, intracel lu lar, cel l membrane transport, sodium, calcium 
and potassium channel protei ns are shown in Figures 7 1 a-h Genes encoding 
card iac muscle protei ns (Myh7, Mybpc3 , My1 1 ,  My13 ,  Mylpf), intercel lular proteins 
(Gja4), membrane transport (Atp l b l ), calcium channel s (Cacna l c, Cacna l g, 
Cacnb 1 ), potassium channels (Kcnj ] 1 )  were significantly (p<O 05 ) increased in  GK 
compared to Control rats Genes encoding potassium channel s (Kcnb ] )  were 
sign ificantly (p<O 05)  decreased in GK compared to Control rats. Genes encoding 
cardiac muscle proteins  (Myh6, Mybpc3 , Tnn2), intercel lular proteins (Gja l ,  Gja4), 
i ntracel lu lar Ca2 t ransport (Atp2a l ,  Ryr2), cel l membrane transport (Atp l a2, 
Atp 1 b 1 ), potassium channel ( Kcnj 2, Kcnj8 )  proteins were significantly (p<0.05)  
increa ed i n  Control/Sucrose compared to Control rats. Genes encoding cardiac 
muscle proteins  (Myh7) were significantly (p<0. 05)  decreased in Control/Sucrose 
compared to Control rats. Genes encoding cardiac muscle proteins (Myh7), 
potassium channel ( Kcnj 1 1 ) proteins were significantly (p<O 05) decreased in  
GKlSucrose compared to Control rats. 
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Figure 6 1 - Expre sion of d· . genes enco mg card lac mu cle proteins i n  GK and Control 
rats fed sucrose-enriched dIets E . xpre slon of genes encoding cardiac mu cle and 
a oClated regu latory proteins (a), intercel lular proteins (b), intracel lular Ca2-
tran port and Ca2 regulatory proteins (c), cel l membrane transport proteins (d), 
calcium channel protei ns (e), odium channel proteins (f) and potassium channel 
protein (g and h) Data are mean ± SEM, n=9 hearts umbers above bars i ndicate 
ign ificant differences between groups * p<0.05 
6.4 D I SCUSSION 
Changes in  the expression of m RNA, caused by diabetes and/or changes in diet, i f  
translated i nto changes in  proteins may cause alterations to  the architecture of cardiac 
muscle proteins, ion channels  and other regulatory proteins, which may in tum have 
i mpl icat ions for electrical and mechanical functions of the heart 
Myh7 encodes the cardiac (beta)-myosin heavy chain and was increased in GK 
compared to Control ventricle, and decreased in ControVSucrose and GKJSucrose 
compared to Control and GK, respect ively Cardiac (beta)-myosin is a 
mechanoenzyme t hat converts the energy from A TP hydrolysis into a mechanical 
force that drives contracti l ity. Altered expression of Myh7 might have impl ications 
for the energetics of contracti l ity in cardiac muscle. Previous studies have shown that 
mutations of Myh7 and other genes l ike Mybpc3 and My13 are associated with  
hypertrophic cardiomyopathy (Fraysse et  ai. , 20 1 2; S ivaramakrishnan e(  aI , 2009) 
Myocyte cel l length was longer and heart weight was greater in GK rats compared to 
Controls findings which are consistent with diabetes induced cardiac hypertrophy_ 
86 
PrevlOu tudie have demon trated increa ed left ventricular wal l  thickness, fibrosi 
and Increa ed col lagenous matrix in GK compared to Control heart (D'Souza el al. . 
20 1 1 , D' ouza el aI , 20 1 3 ) These structural defects might produce restrictive 
mechanical force that impair contract i l ity of the myocardium which may partly 
underl ie the prolonged t ime course of contraction in  GK myocytes compared to 
Controls and the reduced ampl itude of shortening in ControVSucrose and GKJSucrose 
myocyte compared to Control and GK myocytes, respectively. 
Mybpc3 encodes cardiac myosin binding protein C and was increased in  GK 
compared to Control and increased in  Control/Sucrose compared to Control ventricle. 
Mybpc3 is located in  the C-zones of the A-band of the sarcomere and modulates 
actin-myosin i nteraction Previous studies have demonstrated that the early 
consequences of Mybpc3 mutation include altered myofilament Ca2+ sensitivity and 
d iastol ic dysfunction (Fraysse el aI. , 20 1 2) .  The reduction in shorten ing and i ncreased 
Ca2- transient in myocytes from ControVSucrose compared to Control rats might be 
explained by alterations in myofilament Ca2+ sensit ivity. 
Gja l  and Gja5 encodes connexin40 and connexin43 proteins, respectively, and were 
upregulated i n  ControVSucrose compared to Control rats and Gja4 was increased i n  
GK compared to Control ventricle.  The connexins are the pore fonning subunits of 
gap junction channels which are essential for cardiac action potential propagation 
Recent studies have reported an association between nucleotide substitutions in the 
connexin40 and connexin43 genes and cardiac arrhythmias (Delmar & Makita, 20 1 2) 
Cacna 1 g gene encodes for Ca V3 . 1 Ialpha 1 G T -type calcium channels which are 
i mportant for pacemaker activity i n  the sinoatrial node. I nactivation of Cacn
a 1 g 
causes bradycardia and delays i n  atrioventricular conduction (Mangoni e
l at. , 2006). 
In ViVO biotelemetry studies in GK rats have demonstrated a variet
y of electrical 
87 
conduct ion di sturbances including reduced heart rate and prolonged QRS duration and 
QT intervals  and these defects were observed from a young age (Howarth et at. ,  
2008) hanged expression of  Gja l  and Gja5 i n  GK compared to  Control and in  
ontroV ucro e compared to Control and expre sion of  Cacna Ig  in GK compared to 
Control ventricle, may have impl icat ions for electrical conduct ion in the heart 
R yr2 encodes expression of the ryanodine receptor 2 protein and i s  part of a fami  ly of 
receptors which regulate the flow of Ca2-+ out of the SR . Upregulation of Ryr2, if 
associated with i ncreased Ryr2 protein, might increase SR Cah release, which in turn 
might partly contribute to the increased ampl itude of the Ca2
+ 
transient observed in  
m ocytes from ControVSucrose compared to  Control rats. 
Cacna I c and Cacnb 1 genes encode the alpha- l and beta- l subunits of the L-type Ca2 
channel .  Reduced expression of the alpha- l subunit can lead to reduced L-type 
Ca2 current, hypertrophy and heart fai lure i n  mice (Goonasekera et a/. , 20 1 2) 
Upregulation of cacna l c  and Cacnb l i n  GK compared to Control myocytes might 
part ly contribute to the modest i ncrease i n  Ca2� transients in GK compared to Control 
myocytes. 
A wide variety of potassium channel s are i nvolved in  the electrical conduct ion system 
of the heart Potassium channels have roles in estab l i sh ing resting membrane 
potential s and during repolarization of action potential s in pacemaker and cardiac 
muscle ceJ l s. Several genes that encode potassium channel proteins were altered in  
GK, Control/Sucrose and GKfSucrose ventricle. 
Kcnj 2  gene encodes the K ir2. 1 subunits of the inward rectifier potassium channel s i n  
many cel l types i ncluding cardiac myocytes. Kir2 . 1 is  essential i n  the generation of 
88 
the cardiac inward rect ifier h ' h ' . " . current w IC I S  consIdered to contnbute slgmfIcant 
repolarizing current during the terminal phase of the action potential in ventricular 
myocyte uppression of Kir2 I can lead to long-QT syndrome (Miake, Marban & 
u , 2003 ) Upregulation of Kcnj2, if accompanied by increased Kir2 1 protein, i n  
ControlJ ucro e compared to  Control ventricle might be  associated with a reduction 
i n  duration of the terminal pha e of the act ion potential and perhaps an increased 
tendency for development of cardiac arrhythmias 
Kcnj 1 1  gene encodes the Kir6 2 pore-forming subunits of the sarcolemmal ATP-
ensitive potassium channel and are membrane sensors of energy metabol ism that 
uppJy a feedback mechanism capable of adjust ing cel l excitabi l ity to match demand 
(Kane et aI. , 2006). Opening of this channel can protect cardiac myocytes against 
i schemia inj uries by shortening the cardiac act ion potential and reducing Ca2+ influx 
(Wan et af , 2008). I nteresti ngly, in experimental hypertension, knockout of this gene 
predi poses to heart fai lure and death (Kane et aI., 2006) Kcnj 1 1  was i ncreased i n  
GK compared to  Control and decreased in GKlSucrose compared to GK ventricle. 
Kcnb 1 encodes K v2. 1 ,  the voltage-gated potassium channel alpha-subunit of the 
delayed rect ifier potassium channel, which conducts the delayed rectifier potassium 
current and regulates act ion potential duration ( McCrossan et aI., 2009). Previous 
studies have demonstrated decreased expression of Kv2. 1 ,  Kv4.2 and Kv4.3 as early 
as 1 4  days fol lowing streptozotocin induct ion of diabetes in  rat (Qin et aI. , 200 I ) . 
Reduced Kcnb l in  GK compared to Control ventricle might be associated with 
alterations in  action potential durat ion. 
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Chapter 7 
CONCLUSI ONS AND KEY FINDINGS 
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7. CO CLU 10 o KEY FI  T DI  GS 
7. 1 CO CLUSION 
Thi study invest igated the  effect of diabetes mel l itus on cardiac electrophysiology 
and gene expre sion ucro e-enriched diets altered dietary habits i n  GK and Control 
rat and exacerbated diabet ic status in GK rats Subt le changes in expression of gene 
encodi ng a variety of ventricular muscle proteins are associated with changes in  
vent ricu lar myocyte shortening and intracel lular Ca2+ t ransport in ventricular 
myocytes from GK T2DM and Control rats fed a sucrose-enriched diet The longer 
the durat ion of exposure to ri sk factors, the worse are the effects of T2DM on the 
heart as well as the whole body 
7 .2  KEY F I N D ING S 
The major findings of th i s  study were' 
• 
• 
• 
• 
• 
I ncrease in  body weight and non-fast i ng b lood glucose level of rats receiving 
sucrose water compared to rats drinking normal water i n  both groups 
GK and Control rats ate more food and drank less l iquid than GKJSucrose and 
Control/Sucrose rats, 
Al tered cardiomyocyte shorteni ng in GKJSucrose and in Control/Sucrose after 
dietary i ntervent ion 
Altered i ntracel lu lar Ca2
+ transport in GKJSucrose and in Control/Sucrose rats 
Altered myofilament sensit ivity to Ca
2t- i n  GK rats compared to GKJSucrose 
and Control/Sucrose rats 
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• l tered expression of genes encoding a range of ventricular muscle proteins 
and horteni ng and intracel lu lar Ca2 transport in  ventncular t issue for 
GK/ ucrose and Control! ucrose compared to GK and Control rats. 
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